SK286686B6 - Substituované imidazoly a tiazoly, farmaceutická kompozícia s ich obsahom a ich použitie - Google Patents

Info

Publication number

SK286686B6

SK286686B6 SK823-2003A SK8232003A SK286686B6 SK 286686 B6 SK286686 B6 SK 286686B6 SK 8232003 A SK8232003 A SK 8232003A SK 286686 B6 SK286686 B6 SK 286686B6

Authority

SK

Slovakia

Prior art keywords

methyl

group

hydroxy

mmol

imidazol

Prior art date

2000-11-30

Links

• Espacenet
• Global Dossier
• Discuss

• 150000002460 imidazoles Chemical class 0.000 title claims abstract description 5
• 150000003557 thiazoles Chemical class 0.000 title claims abstract description 5
• 239000008194 pharmaceutical composition Chemical class 0.000 title claims description 4
• 150000001875 compounds Chemical class 0.000 claims abstract description 194
• 239000003814 drug Substances 0.000 claims abstract description 9
• 230000002401 inhibitory effect Effects 0.000 claims abstract description 8
• 238000004519 manufacturing process Methods 0.000 claims abstract description 6
• -1 azido, carboxy Chemical group 0.000 claims description 103
• 125000003118 aryl group Chemical group 0.000 claims description 59
• 125000000217 alkyl group Chemical group 0.000 claims description 58
• 125000000623 heterocyclic group Chemical group 0.000 claims description 49
• 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 claims description 38
• 125000000753 cycloalkyl group Chemical group 0.000 claims description 36
• 125000004093 cyano group Chemical group *C#N 0.000 claims description 26
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 23
• 229910052739 hydrogen Inorganic materials 0.000 claims description 23
• 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 22
• 239000001257 hydrogen Substances 0.000 claims description 21
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 20
• 125000003545 alkoxy group Chemical group 0.000 claims description 19
• 229910052736 halogen Inorganic materials 0.000 claims description 19
• 150000002367 halogens Chemical class 0.000 claims description 18
• 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 18
• 150000003839 salts Chemical class 0.000 claims description 18
• 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 17
• 125000004103 aminoalkyl group Chemical group 0.000 claims description 17
• 125000003710 aryl alkyl group Chemical group 0.000 claims description 17
• 125000001188 haloalkyl group Chemical group 0.000 claims description 17
• 229910052757 nitrogen Inorganic materials 0.000 claims description 15
• 125000004104 aryloxy group Chemical group 0.000 claims description 14
• 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 14
• 125000001424 substituent group Chemical group 0.000 claims description 14
• 125000005309 thioalkoxy group Chemical group 0.000 claims description 14
• 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 13
• 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 13
• 125000004043 oxo group Chemical group O=* 0.000 claims description 13
• 125000003342 alkenyl group Chemical group 0.000 claims description 12
• 125000000304 alkynyl group Chemical group 0.000 claims description 12
• 125000004391 aryl sulfonyl group Chemical group 0.000 claims description 12
• 206010028980 Neoplasm Diseases 0.000 claims description 11
• 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims description 11
• 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims description 11
• 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 11
• 125000004971 nitroalkyl group Chemical group 0.000 claims description 11
• 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 11
• 125000000446 sulfanediyl group Chemical group *S* 0.000 claims description 10
• 125000003368 amide group Chemical group 0.000 claims description 9
• 125000004432 carbon atom Chemical group C* 0.000 claims description 9
• 125000004966 cyanoalkyl group Chemical group 0.000 claims description 9
• 229910052717 sulfur Inorganic materials 0.000 claims description 9
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
• 125000003277 amino group Chemical group 0.000 claims description 8
• 238000011282 treatment Methods 0.000 claims description 8
• 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 7
• 238000002360 preparation method Methods 0.000 claims description 7
• 125000004419 alkynylene group Chemical group 0.000 claims description 6
• 125000004438 haloalkoxy group Chemical group 0.000 claims description 6
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
• 125000004450 alkenylene group Chemical group 0.000 claims description 5
• 229910052799 carbon Inorganic materials 0.000 claims description 5
• QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 5
• 125000002619 bicyclic group Chemical group 0.000 claims description 4
• 201000011510 cancer Diseases 0.000 claims description 4
• 125000004122 cyclic group Chemical group 0.000 claims description 4
• 229910052760 oxygen Inorganic materials 0.000 claims description 4
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
• 125000005708 carbonyloxy group Chemical group [*:2]OC([*:1])=O 0.000 claims description 3
• 125000004181 carboxyalkyl group Chemical group 0.000 claims description 3
• 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 3
• 125000005842 heteroatom Chemical group 0.000 claims description 3
• 125000004665 trialkylsilyl group Chemical group 0.000 claims description 3
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
• 239000011203 carbon fibre reinforced carbon Substances 0.000 claims description 2
• 239000001301 oxygen Substances 0.000 claims description 2
• 239000011593 sulfur Substances 0.000 claims description 2
• 125000001475 halogen functional group Chemical group 0.000 claims 10
• 125000004356 hydroxy functional group Chemical group O* 0.000 claims 10
• 125000001589 carboacyl group Chemical group 0.000 claims 8
• YIXYMJBIWVLYJN-UHFFFAOYSA-N 4-[2-(4-cyanophenyl)-2-hydroxy-2-(3-methylimidazol-4-yl)ethoxy]-3-(3,4-difluorophenyl)benzonitrile Chemical compound CN1C=NC=C1C(O)(C=1C=CC(=CC=1)C#N)COC1=CC=C(C#N)C=C1C1=CC=C(F)C(F)=C1 YIXYMJBIWVLYJN-UHFFFAOYSA-N 0.000 claims 1
• 230000001225 therapeutic effect Effects 0.000 claims 1
• 239000000203 mixture Substances 0.000 abstract description 89
• 108010007508 Farnesyltranstransferase Proteins 0.000 abstract description 6
• 102000007317 Farnesyltranstransferase Human genes 0.000 abstract description 6
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 298
• 239000000047 product Substances 0.000 description 250
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 138
• 239000000243 solution Substances 0.000 description 113
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 98
• VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 97
• 239000012141 concentrate Substances 0.000 description 96
• 235000008504 concentrate Nutrition 0.000 description 96
• 235000019439 ethyl acetate Nutrition 0.000 description 95
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 93
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 86
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 82
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 75
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 75
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 69
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 69
• 238000003818 flash chromatography Methods 0.000 description 67
• 238000006243 chemical reaction Methods 0.000 description 65
• 239000000741 silica gel Substances 0.000 description 63
• 229910002027 silica gel Inorganic materials 0.000 description 63
• HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 59
• JFDZBHWFFUWGJE-UHFFFAOYSA-N benzenecarbonitrile Natural products N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 54
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 51
• 239000003480 eluent Substances 0.000 description 42
• KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 40
• 239000012267 brine Substances 0.000 description 38
• HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 38
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 36
• 239000000284 extract Substances 0.000 description 34
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 33
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 29
• 229910000069 nitrogen hydride Inorganic materials 0.000 description 29
• 239000002585 base Substances 0.000 description 28
• 239000002904 solvent Substances 0.000 description 27
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 26
• 238000010992 reflux Methods 0.000 description 26
• 239000011734 sodium Substances 0.000 description 25
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 23
• 238000000034 method Methods 0.000 description 22
• 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 21
• 239000012074 organic phase Substances 0.000 description 21
• VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 20
• PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 18
• NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 17
• 238000000746 purification Methods 0.000 description 16
• 229920006395 saturated elastomer Polymers 0.000 description 16
• CMHPUBKZZPSUIQ-UHFFFAOYSA-N 1,3-benzodioxol-5-ylboronic acid Chemical group OB(O)C1=CC=C2OCOC2=C1 CMHPUBKZZPSUIQ-UHFFFAOYSA-N 0.000 description 15
• 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 15
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
• 239000012071 phase Substances 0.000 description 15
• RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 14
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 14
• 239000000725 suspension Substances 0.000 description 14
• 125000005843 halogen group Chemical group 0.000 description 13
• 239000007787 solid Substances 0.000 description 13
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
• 125000002252 acyl group Chemical group 0.000 description 12
• 239000003054 catalyst Substances 0.000 description 12
• 229910052763 palladium Inorganic materials 0.000 description 12
• 229910000104 sodium hydride Inorganic materials 0.000 description 12
• 238000003786 synthesis reaction Methods 0.000 description 12
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 12
• SDEAGACSNFSZCU-UHFFFAOYSA-N (3-chlorophenyl)boronic acid Chemical group OB(O)C1=CC=CC(Cl)=C1 SDEAGACSNFSZCU-UHFFFAOYSA-N 0.000 description 11
• 230000015572 biosynthetic process Effects 0.000 description 11
• 230000035484 reaction time Effects 0.000 description 11
• 238000003756 stirring Methods 0.000 description 11
• OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 10
• SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 10
• OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 10
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid group Chemical class C(CC(O)(C(=O)O)CC(=O)O)(=O)O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 10
• 230000005764 inhibitory process Effects 0.000 description 10
• NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 10
• UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
• MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 9
• 239000002253 acid Substances 0.000 description 9
• UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 9
• BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 8
• JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 8
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
• 238000004458 analytical method Methods 0.000 description 8
• 238000010168 coupling process Methods 0.000 description 8
• RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 8
• WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 7
• 101150003085 Pdcl gene Proteins 0.000 description 7
• XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 7
• DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 7
• 238000010521 absorption reaction Methods 0.000 description 7
• 150000002431 hydrogen Chemical class 0.000 description 7
• UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 7
• 102000016914 ras Proteins Human genes 0.000 description 7
• 108010014186 ras Proteins Proteins 0.000 description 7
• WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 6
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
• XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 6
• KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
• 230000008878 coupling Effects 0.000 description 6
• 238000005859 coupling reaction Methods 0.000 description 6
• 239000012458 free base Substances 0.000 description 6
• YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 6
• AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 6
• 239000000843 powder Substances 0.000 description 6
• MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 6
• FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 6
• INEMHABDFCKBID-UHFFFAOYSA-N 3-chloro-4-methylbenzonitrile Chemical compound CC1=CC=C(C#N)C=C1Cl INEMHABDFCKBID-UHFFFAOYSA-N 0.000 description 5
• OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 5
• 102000004190 Enzymes Human genes 0.000 description 5
• 108090000790 Enzymes Proteins 0.000 description 5
• 239000008346 aqueous phase Substances 0.000 description 5
• XJHCXCQVJFPJIK-UHFFFAOYSA-M caesium fluoride Chemical compound [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 description 5
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
• 238000009472 formulation Methods 0.000 description 5
• 239000011541 reaction mixture Substances 0.000 description 5
• 229910001923 silver oxide Inorganic materials 0.000 description 5
• 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 5
• NLLGFYPSWCMUIV-UHFFFAOYSA-N (3-methoxyphenyl)boronic acid Chemical group COC1=CC=CC(B(O)O)=C1 NLLGFYPSWCMUIV-UHFFFAOYSA-N 0.000 description 4
• VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
• VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 4
• 239000004342 Benzoyl peroxide Substances 0.000 description 4
• OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 4
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
• 239000005909 Kieselgur Substances 0.000 description 4
• BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
• SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 4
• WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
• HUOFUOCSQCYFPW-UHFFFAOYSA-N [4-(trifluoromethoxy)phenyl]boronic acid Chemical group OB(O)C1=CC=C(OC(F)(F)F)C=C1 HUOFUOCSQCYFPW-UHFFFAOYSA-N 0.000 description 4
• 150000007513 acids Chemical class 0.000 description 4
• 239000000908 ammonium hydroxide Substances 0.000 description 4
• 235000019400 benzoyl peroxide Nutrition 0.000 description 4
• 239000003638 chemical reducing agent Substances 0.000 description 4
• 235000015165 citric acid Nutrition 0.000 description 4
• NKLCNNUWBJBICK-UHFFFAOYSA-N dess–martin periodinane Chemical compound C1=CC=C2I(OC(=O)C)(OC(C)=O)(OC(C)=O)OC(=O)C2=C1 NKLCNNUWBJBICK-UHFFFAOYSA-N 0.000 description 4
• 239000003085 diluting agent Substances 0.000 description 4
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
• 230000000694 effects Effects 0.000 description 4
• 239000012065 filter cake Substances 0.000 description 4
• 238000004128 high performance liquid chromatography Methods 0.000 description 4
• 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 4
• ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 4
• 239000012044 organic layer Substances 0.000 description 4
• CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 4
• 125000004430 oxygen atom Chemical group O* 0.000 description 4
• YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 4
• BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
• NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Substances [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 4
• 229940002612 prodrug Drugs 0.000 description 4
• 239000000651 prodrug Substances 0.000 description 4
• 238000000926 separation method Methods 0.000 description 4
• 239000002002 slurry Substances 0.000 description 4
• 229910000029 sodium carbonate Inorganic materials 0.000 description 4
• 235000017550 sodium carbonate Nutrition 0.000 description 4
• 239000007858 starting material Substances 0.000 description 4
• 238000001665 trituration Methods 0.000 description 4
• NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 3
• NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 3
• DKYRKAIKWFHQHM-UHFFFAOYSA-N (3,5-dichlorophenyl)boronic acid Chemical group OB(O)C1=CC(Cl)=CC(Cl)=C1 DKYRKAIKWFHQHM-UHFFFAOYSA-N 0.000 description 3
• QWQBQRYFWNIDOC-UHFFFAOYSA-N (3,5-difluorophenyl)boronic acid Chemical compound OB(O)C1=CC(F)=CC(F)=C1 QWQBQRYFWNIDOC-UHFFFAOYSA-N 0.000 description 3
• CHCWUTJYLUBETR-UHFFFAOYSA-N (3-ethoxyphenyl)boronic acid Chemical group CCOC1=CC=CC(B(O)O)=C1 CHCWUTJYLUBETR-UHFFFAOYSA-N 0.000 description 3
• OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 3
• FFNVQNRYTPFDDP-UHFFFAOYSA-N 2-cyanopyridine Chemical compound N#CC1=CC=CC=N1 FFNVQNRYTPFDDP-UHFFFAOYSA-N 0.000 description 3
• JKCYKISVUIVZCS-UHFFFAOYSA-N 3-bromo-4-fluorobenzonitrile Chemical compound FC1=CC=C(C#N)C=C1Br JKCYKISVUIVZCS-UHFFFAOYSA-N 0.000 description 3
• WZWIQYMTQZCSKI-UHFFFAOYSA-N 4-cyanobenzaldehyde Chemical compound O=CC1=CC=C(C#N)C=C1 WZWIQYMTQZCSKI-UHFFFAOYSA-N 0.000 description 3
• SZRHWHHXVXSGMT-UHFFFAOYSA-N 5-bromo-2,2-difluoro-1,3-benzodioxole Chemical compound C1=C(Br)C=C2OC(F)(F)OC2=C1 SZRHWHHXVXSGMT-UHFFFAOYSA-N 0.000 description 3
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
• NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 3
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
• 150000001499 aryl bromides Chemical class 0.000 description 3
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
• 239000004305 biphenyl Substances 0.000 description 3
• 230000037396 body weight Effects 0.000 description 3
• 125000005997 bromomethyl group Chemical group 0.000 description 3
• 239000000872 buffer Substances 0.000 description 3
• 239000006227 byproduct Substances 0.000 description 3
• 239000003795 chemical substances by application Substances 0.000 description 3
• 239000012043 crude product Substances 0.000 description 3
• 229940043279 diisopropylamine Drugs 0.000 description 3
• 235000011180 diphosphates Nutrition 0.000 description 3
• 229940079593 drug Drugs 0.000 description 3
• 230000006126 farnesylation Effects 0.000 description 3
• 239000000706 filtrate Substances 0.000 description 3
• 239000011521 glass Substances 0.000 description 3
• 150000004820 halides Chemical class 0.000 description 3
• 230000026030 halogenation Effects 0.000 description 3
• 238000005658 halogenation reaction Methods 0.000 description 3
• 238000010438 heat treatment Methods 0.000 description 3
• 150000002430 hydrocarbons Chemical group 0.000 description 3
• 239000010410 layer Substances 0.000 description 3
• KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 3
• JGZKUKYUQJUUNE-UHFFFAOYSA-L magnesium;ethoxyethane;dibromide Chemical compound [Mg+2].[Br-].[Br-].CCOCC JGZKUKYUQJUUNE-UHFFFAOYSA-L 0.000 description 3
• 230000014759 maintenance of location Effects 0.000 description 3
• 239000003921 oil Substances 0.000 description 3
• 239000000546 pharmaceutical excipient Substances 0.000 description 3
• 239000006187 pill Substances 0.000 description 3
• 229920000642 polymer Polymers 0.000 description 3
• XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 3
• 229960004618 prednisone Drugs 0.000 description 3
• 238000002953 preparative HPLC Methods 0.000 description 3
• 230000008569 process Effects 0.000 description 3
• 230000035755 proliferation Effects 0.000 description 3
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
• 238000010791 quenching Methods 0.000 description 3
• 150000003254 radicals Chemical class 0.000 description 3
• RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 3
• 235000012239 silicon dioxide Nutrition 0.000 description 3
• 239000007921 spray Substances 0.000 description 3
• 238000010561 standard procedure Methods 0.000 description 3
• 239000003826 tablet Substances 0.000 description 3
• 239000000454 talc Substances 0.000 description 3
• 235000012222 talc Nutrition 0.000 description 3
• 229910052623 talc Inorganic materials 0.000 description 3
• JMXKSZRRTHPKDL-UHFFFAOYSA-N titanium ethoxide Chemical compound [Ti+4].CC[O-].CC[O-].CC[O-].CC[O-] JMXKSZRRTHPKDL-UHFFFAOYSA-N 0.000 description 3
• JPBUWNCKKLDKEK-UHFFFAOYSA-N triethyl-(1-methylimidazol-2-yl)silane Chemical compound CC[Si](CC)(CC)C1=NC=CN1C JPBUWNCKKLDKEK-UHFFFAOYSA-N 0.000 description 3
• OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 3
• 229960004528 vincristine Drugs 0.000 description 3
• OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 3
• OTTIPUIRDXSIBG-UHFFFAOYSA-N (2,2-difluoro-1,3-benzodioxol-5-yl)boronic acid Chemical compound OB(O)C1=CC=C2OC(F)(F)OC2=C1 OTTIPUIRDXSIBG-UHFFFAOYSA-N 0.000 description 2
• JKIGHOARKAIPJI-UHFFFAOYSA-N (3,4-dichlorophenyl)boronic acid Chemical group OB(O)C1=CC=C(Cl)C(Cl)=C1 JKIGHOARKAIPJI-UHFFFAOYSA-N 0.000 description 2
• KNXQDJCZSVHEIW-UHFFFAOYSA-N (3-fluorophenyl)boronic acid Chemical group OB(O)C1=CC=CC(F)=C1 KNXQDJCZSVHEIW-UHFFFAOYSA-N 0.000 description 2
• KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 2
• HTFGYEUMDFBWTG-UHFFFAOYSA-N 1-(3-chlorophenyl)-6-[[(4-cyanophenyl)-(3-methylimidazol-4-yl)methoxy]methyl]-4-oxopyridine-3-carbonitrile Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=CC(=O)C(C#N)=CN1C1=CC=CC(Cl)=C1 HTFGYEUMDFBWTG-UHFFFAOYSA-N 0.000 description 2
• ZEMZPXWZVTUONV-UHFFFAOYSA-N 2-(2-dicyclohexylphosphanylphenyl)-n,n-dimethylaniline Chemical group CN(C)C1=CC=CC=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 ZEMZPXWZVTUONV-UHFFFAOYSA-N 0.000 description 2
• ANOOZLFFCNANTR-UHFFFAOYSA-N 2-fluoro-3-iodo-5-methylpyridine Chemical compound CC1=CN=C(F)C(I)=C1 ANOOZLFFCNANTR-UHFFFAOYSA-N 0.000 description 2
• ZBCKVQVOMVOREE-UHFFFAOYSA-N 3-(1,3-benzodioxol-5-yl)-4-[2-(4-cyanophenyl)-2-hydroxy-2-(3-methylimidazol-4-yl)ethoxy]benzonitrile Chemical compound CN1C=NC=C1C(O)(C=1C=CC(=CC=1)C#N)COC1=CC=C(C#N)C=C1C1=CC=C(OCO2)C2=C1 ZBCKVQVOMVOREE-UHFFFAOYSA-N 0.000 description 2
• CJOWDGQKVQMHOD-UHFFFAOYSA-N 3-(1,3-benzodioxol-5-yl)-4-[[(4-cyanophenyl)-(3-methylimidazol-4-yl)methoxy]methyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=CC=C(C#N)C=C1C1=CC=C(OCO2)C2=C1 CJOWDGQKVQMHOD-UHFFFAOYSA-N 0.000 description 2
• RGXWUSMPBUPQSB-UHFFFAOYSA-N 3-(3-chlorophenyl)-4-[[(4-cyanophenyl)-(3-methylimidazol-4-yl)methoxy]methyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=CC=C(C#N)C=C1C1=CC=CC(Cl)=C1 RGXWUSMPBUPQSB-UHFFFAOYSA-N 0.000 description 2
• SYHJILPZUNKNHQ-UHFFFAOYSA-N 3-phenylbenzonitrile Chemical compound N#CC1=CC=CC(C=2C=CC=CC=2)=C1 SYHJILPZUNKNHQ-UHFFFAOYSA-N 0.000 description 2
• HEUVRFNVTLGKMZ-SANMLTNESA-N 4-[(2s)-2-(4-cyanophenyl)-2-hydroxy-2-(3-methylimidazol-4-yl)ethoxy]-3-[4-(trifluoromethoxy)phenyl]benzonitrile Chemical compound CN1C=NC=C1[C@@](O)(C=1C=CC(=CC=1)C#N)COC1=CC=C(C#N)C=C1C1=CC=C(OC(F)(F)F)C=C1 HEUVRFNVTLGKMZ-SANMLTNESA-N 0.000 description 2
• KNSXROXYRXJMQI-UHFFFAOYSA-N 4-[(4-chloro-2-phenylphenyl)methoxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=CC=C(Cl)C=C1C1=CC=CC=C1 KNSXROXYRXJMQI-UHFFFAOYSA-N 0.000 description 2
• XNZAPPNXJBPOOJ-UHFFFAOYSA-N 4-[2-(4-cyanophenyl)-2-hydroxy-2-(3-methylimidazol-4-yl)ethoxy]-3-(3-fluorophenyl)benzonitrile Chemical compound CN1C=NC=C1C(O)(C=1C=CC(=CC=1)C#N)COC1=CC=C(C#N)C=C1C1=CC=CC(F)=C1 XNZAPPNXJBPOOJ-UHFFFAOYSA-N 0.000 description 2
• NNBUZWWOUGQOON-UHFFFAOYSA-N 4-[[(4-cyanophenyl)-(3-methylimidazol-4-yl)methoxy]methyl]-3-(6-oxo-1-propylpyridin-3-yl)benzonitrile Chemical compound C1=CC(=O)N(CCC)C=C1C1=CC(C#N)=CC=C1COC(C=1C=CC(=CC=1)C#N)C1=CN=CN1C NNBUZWWOUGQOON-UHFFFAOYSA-N 0.000 description 2
• IFBXFLCRVVJFBJ-UHFFFAOYSA-N 4-[[6-chloro-2-(3-chlorophenyl)pyridin-3-yl]methoxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=CC=C(Cl)N=C1C1=CC=CC(Cl)=C1 IFBXFLCRVVJFBJ-UHFFFAOYSA-N 0.000 description 2
• ZFBKYGFPUCUYIF-UHFFFAOYSA-N 4-amino-2-chlorobenzonitrile Chemical compound NC1=CC=C(C#N)C(Cl)=C1 ZFBKYGFPUCUYIF-UHFFFAOYSA-N 0.000 description 2
• HGXWRDPQFZKOLZ-UHFFFAOYSA-N 4-bromo-2-fluorobenzonitrile Chemical compound FC1=CC(Br)=CC=C1C#N HGXWRDPQFZKOLZ-UHFFFAOYSA-N 0.000 description 2
• YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical group CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
• DPUVICGLBCCTDM-UHFFFAOYSA-N 5-iodo-1-methylimidazole Chemical compound CN1C=NC=C1I DPUVICGLBCCTDM-UHFFFAOYSA-N 0.000 description 2
• HSMBIOOZBSGLTB-UHFFFAOYSA-N 6-[[(4-cyanophenyl)-(3-methylimidazol-4-yl)methoxy]methyl]-5-(3,5-dichlorophenyl)-1-methyl-2-oxopyridine-3-carbonitrile Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=C(C=2C=C(Cl)C=C(Cl)C=2)C=C(C#N)C(=O)N1C HSMBIOOZBSGLTB-UHFFFAOYSA-N 0.000 description 2
• XIPVCWJXWJDNCA-UHFFFAOYSA-N 6-[[(4-cyanophenyl)-(3-methylimidazol-4-yl)methoxy]methyl]-5-(3,5-difluorophenyl)-1-methyl-2-oxopyridine-3-carbonitrile Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=C(C=2C=C(F)C=C(F)C=2)C=C(C#N)C(=O)N1C XIPVCWJXWJDNCA-UHFFFAOYSA-N 0.000 description 2
• DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
• NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
• XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
• 239000004215 Carbon black (E152) Substances 0.000 description 2
• CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
• FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
• AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
• CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
• MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 2
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
• 206010027476 Metastases Diseases 0.000 description 2
• 241001465754 Metazoa Species 0.000 description 2
• 229920001410 Microfiber Polymers 0.000 description 2
• ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 description 2
• MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 2
• 229910019142 PO4 Inorganic materials 0.000 description 2
• 239000004952 Polyamide Substances 0.000 description 2
• KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
• PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
• 229920002472 Starch Polymers 0.000 description 2
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
• XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
• UWDFWVLAHRQSKK-UHFFFAOYSA-N [3-(trifluoromethoxy)phenyl]boronic acid Chemical group OB(O)C1=CC=CC(OC(F)(F)F)=C1 UWDFWVLAHRQSKK-UHFFFAOYSA-N 0.000 description 2
• 150000001242 acetic acid derivatives Chemical class 0.000 description 2
• 239000000654 additive Substances 0.000 description 2
• 230000000996 additive effect Effects 0.000 description 2
• 239000002671 adjuvant Substances 0.000 description 2
• 208000026935 allergic disease Diseases 0.000 description 2
• WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 2
• 150000001412 amines Chemical class 0.000 description 2
• 229910021529 ammonia Inorganic materials 0.000 description 2
• CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
• OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
• 230000008901 benefit Effects 0.000 description 2
• 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
• KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
• 239000004327 boric acid Substances 0.000 description 2
• 210000004556 brain Anatomy 0.000 description 2
• 150000001649 bromium compounds Chemical class 0.000 description 2
• FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
• 229910000024 caesium carbonate Inorganic materials 0.000 description 2
• 239000000378 calcium silicate Substances 0.000 description 2
• 229910052918 calcium silicate Inorganic materials 0.000 description 2
• OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 2
• 239000002775 capsule Substances 0.000 description 2
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
• 239000000969 carrier Substances 0.000 description 2
• 230000003197 catalytic effect Effects 0.000 description 2
• 210000004027 cell Anatomy 0.000 description 2
• BJDCWCLMFKKGEE-CMDXXVQNSA-N chembl252518 Chemical compound C([C@@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2O[C@H](O)[C@@H]4C BJDCWCLMFKKGEE-CMDXXVQNSA-N 0.000 description 2
• 230000000973 chemotherapeutic effect Effects 0.000 description 2
• 238000002512 chemotherapy Methods 0.000 description 2
• IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 2
• 229960004397 cyclophosphamide Drugs 0.000 description 2
• WMKGGPCROCCUDY-PHEQNACWSA-N dibenzylideneacetone Chemical compound C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 WMKGGPCROCCUDY-PHEQNACWSA-N 0.000 description 2
• YNHIGQDRGKUECZ-UHFFFAOYSA-N dichloropalladium;triphenylphosphanium Chemical compound Cl[Pd]Cl.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-N 0.000 description 2
• 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
• CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Chemical compound CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 description 2
• XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 2
• 201000010099 disease Diseases 0.000 description 2
• 208000035475 disorder Diseases 0.000 description 2
• 239000002552 dosage form Substances 0.000 description 2
• VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 description 2
• 229960005420 etoposide Drugs 0.000 description 2
• WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 2
• 239000000499 gel Substances 0.000 description 2
• 229930195733 hydrocarbon Natural products 0.000 description 2
• 238000005984 hydrogenation reaction Methods 0.000 description 2
• 238000000338 in vitro Methods 0.000 description 2
• 238000001727 in vivo Methods 0.000 description 2
• 239000003999 initiator Substances 0.000 description 2
• 150000004694 iodide salts Chemical class 0.000 description 2
• 229910052740 iodine Inorganic materials 0.000 description 2
• INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
• 230000007794 irritation Effects 0.000 description 2
• 229960004873 levomenthol Drugs 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
• 239000012528 membrane Substances 0.000 description 2
• 230000002503 metabolic effect Effects 0.000 description 2
• 230000009401 metastasis Effects 0.000 description 2
• 229960000485 methotrexate Drugs 0.000 description 2
• 239000004530 micro-emulsion Substances 0.000 description 2
• 239000003658 microfiber Substances 0.000 description 2
• DZYGQZQTEVKSFD-UHFFFAOYSA-N n-(3-chlorophenyl)-5-cyano-2-[[(4-cyanophenyl)-(3-methylimidazol-4-yl)methoxy]methyl]benzamide Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=CC=C(C#N)C=C1C(=O)NC1=CC=CC(Cl)=C1 DZYGQZQTEVKSFD-UHFFFAOYSA-N 0.000 description 2
• GOWYQYXITBPMTO-UHFFFAOYSA-N n-[5-cyano-2-[[(4-cyanophenyl)-(3-methylimidazol-4-yl)methoxy]methyl]phenyl]thiophene-2-sulfonamide Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=CC=C(C#N)C=C1NS(=O)(=O)C1=CC=CS1 GOWYQYXITBPMTO-UHFFFAOYSA-N 0.000 description 2
• HUMMCEUVDBVXTQ-UHFFFAOYSA-N naphthalen-1-ylboronic acid Chemical group C1=CC=C2C(B(O)O)=CC=CC2=C1 HUMMCEUVDBVXTQ-UHFFFAOYSA-N 0.000 description 2
• 239000012299 nitrogen atmosphere Substances 0.000 description 2
• 230000003287 optical effect Effects 0.000 description 2
• 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 2
• 235000021317 phosphate Nutrition 0.000 description 2
• XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
• 229920002647 polyamide Polymers 0.000 description 2
• 229920001223 polyethylene glycol Polymers 0.000 description 2
• 229910000027 potassium carbonate Inorganic materials 0.000 description 2
• 235000011181 potassium carbonates Nutrition 0.000 description 2
• NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
• 239000011698 potassium fluoride Substances 0.000 description 2
• LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 2
• 125000006239 protecting group Chemical group 0.000 description 2
• 239000003528 protein farnesyltransferase inhibitor Substances 0.000 description 2
• 102000004169 proteins and genes Human genes 0.000 description 2
• 108090000623 proteins and genes Proteins 0.000 description 2
• 238000001959 radiotherapy Methods 0.000 description 2
• 210000000664 rectum Anatomy 0.000 description 2
• 230000000979 retarding effect Effects 0.000 description 2
• 229930195734 saturated hydrocarbon Natural products 0.000 description 2
• LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
• 239000008107 starch Substances 0.000 description 2
• 235000019698 starch Nutrition 0.000 description 2
• 239000000758 substrate Substances 0.000 description 2
• BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
• 239000000375 suspending agent Substances 0.000 description 2
• 229940095064 tartrate Drugs 0.000 description 2
• 238000012360 testing method Methods 0.000 description 2
• FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
• VNNLHYZDXIBHKZ-UHFFFAOYSA-N thiophene-2-sulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CS1 VNNLHYZDXIBHKZ-UHFFFAOYSA-N 0.000 description 2
• FWPIDFUJEMBDLS-UHFFFAOYSA-L tin(II) chloride dihydrate Chemical compound O.O.Cl[Sn]Cl FWPIDFUJEMBDLS-UHFFFAOYSA-L 0.000 description 2
• 230000001988 toxicity Effects 0.000 description 2
• 231100000419 toxicity Toxicity 0.000 description 2
• 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
• CWMFRHBXRUITQE-UHFFFAOYSA-N trimethylsilylacetylene Chemical group C[Si](C)(C)C#C CWMFRHBXRUITQE-UHFFFAOYSA-N 0.000 description 2
• LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
• NHDIQVFFNDKAQU-UHFFFAOYSA-N tripropan-2-yl borate Chemical compound CC(C)OB(OC(C)C)OC(C)C NHDIQVFFNDKAQU-UHFFFAOYSA-N 0.000 description 2
• 238000009736 wetting Methods 0.000 description 2
• 239000000080 wetting agent Substances 0.000 description 2
• 239000008096 xylene Substances 0.000 description 2
• 239000011701 zinc Substances 0.000 description 2
• TYIKXPOMOYDGCS-UHFFFAOYSA-N (2,3-dichlorophenyl)boronic acid Chemical group OB(O)C1=CC=CC(Cl)=C1Cl TYIKXPOMOYDGCS-UHFFFAOYSA-N 0.000 description 1
• QOZLFNQLIKOGDR-UHFFFAOYSA-N (2,5-dimethoxyphenyl)boronic acid Chemical group COC1=CC=C(OC)C(B(O)O)=C1 QOZLFNQLIKOGDR-UHFFFAOYSA-N 0.000 description 1
• ZKAOVABYLXQUTI-UHFFFAOYSA-N (2-acetylphenyl)boronic acid Chemical group CC(=O)C1=CC=CC=C1B(O)O ZKAOVABYLXQUTI-UHFFFAOYSA-N 0.000 description 1
• RRCMGJCFMJBHQC-UHFFFAOYSA-N (2-chlorophenyl)boronic acid Chemical group OB(O)C1=CC=CC=C1Cl RRCMGJCFMJBHQC-UHFFFAOYSA-N 0.000 description 1
• HMPDWSBKPCOQDW-UHFFFAOYSA-N (2-chloropyridin-3-yl)methanol Chemical compound OCC1=CC=CN=C1Cl HMPDWSBKPCOQDW-UHFFFAOYSA-N 0.000 description 1
• ROEQGIFOWRQYHD-UHFFFAOYSA-N (2-methoxyphenyl)boronic acid Chemical group COC1=CC=CC=C1B(O)O ROEQGIFOWRQYHD-UHFFFAOYSA-N 0.000 description 1
• NSJVYHOPHZMZPN-UHFFFAOYSA-N (2-methylphenyl)boronic acid Chemical group CC1=CC=CC=C1B(O)O NSJVYHOPHZMZPN-UHFFFAOYSA-N 0.000 description 1
• RULQUTYJXDLRFL-UHFFFAOYSA-N (3,4,5-trimethoxyphenyl)boronic acid Chemical group COC1=CC(B(O)O)=CC(OC)=C1OC RULQUTYJXDLRFL-UHFFFAOYSA-N 0.000 description 1
• RMGYQBHKEWWTOY-UHFFFAOYSA-N (3,4-difluorophenyl)boronic acid Chemical group OB(O)C1=CC=C(F)C(F)=C1 RMGYQBHKEWWTOY-UHFFFAOYSA-N 0.000 description 1
• RCVDPBFUMYUKPB-UHFFFAOYSA-N (3,4-dimethoxyphenyl)boronic acid Chemical group COC1=CC=C(B(O)O)C=C1OC RCVDPBFUMYUKPB-UHFFFAOYSA-N 0.000 description 1
• KDVZJKOYSOFXRV-UHFFFAOYSA-N (3,4-dimethylphenyl)boronic acid Chemical group CC1=CC=C(B(O)O)C=C1C KDVZJKOYSOFXRV-UHFFFAOYSA-N 0.000 description 1
• IBTSWKLSEOGJGJ-UHFFFAOYSA-N (3-acetamidophenyl)boronic acid Chemical group CC(=O)NC1=CC=CC(B(O)O)=C1 IBTSWKLSEOGJGJ-UHFFFAOYSA-N 0.000 description 1
• WJDZZXIDQYKVDG-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)boronic acid Chemical group OB(O)C1=CC=C(F)C(Cl)=C1 WJDZZXIDQYKVDG-UHFFFAOYSA-N 0.000 description 1
• XDBHWPLGGBLUHH-UHFFFAOYSA-N (3-cyanophenyl)boronic acid Chemical group OB(O)C1=CC=CC(C#N)=C1 XDBHWPLGGBLUHH-UHFFFAOYSA-N 0.000 description 1
• HJBGZJMKTOMQRR-UHFFFAOYSA-N (3-formylphenyl)boronic acid Chemical group OB(O)C1=CC=CC(C=O)=C1 HJBGZJMKTOMQRR-UHFFFAOYSA-N 0.000 description 1
• BJQCPCFFYBKRLM-UHFFFAOYSA-N (3-methylphenyl)boronic acid Chemical group CC1=CC=CC(B(O)O)=C1 BJQCPCFFYBKRLM-UHFFFAOYSA-N 0.000 description 1
• OBQRODBYVNIZJU-UHFFFAOYSA-N (4-acetylphenyl)boronic acid Chemical group CC(=O)C1=CC=C(B(O)O)C=C1 OBQRODBYVNIZJU-UHFFFAOYSA-N 0.000 description 1
• CAYQIZIAYYNFCS-UHFFFAOYSA-N (4-chlorophenyl)boronic acid Chemical group OB(O)C1=CC=C(Cl)C=C1 CAYQIZIAYYNFCS-UHFFFAOYSA-N 0.000 description 1
• MNJYZNVROSZZQC-UHFFFAOYSA-N (4-tert-butylphenyl)boronic acid Chemical group CC(C)(C)C1=CC=C(B(O)O)C=C1 MNJYZNVROSZZQC-UHFFFAOYSA-N 0.000 description 1
• DEQOVKFWRPOPQP-UHFFFAOYSA-N (5-formylthiophen-2-yl)boronic acid Chemical group OB(O)C1=CC=C(C=O)S1 DEQOVKFWRPOPQP-UHFFFAOYSA-N 0.000 description 1
• OJBYZWHAPXIJID-UHFFFAOYSA-N (6-fluoropyridin-3-yl)boronic acid Chemical compound OB(O)C1=CC=C(F)N=C1 OJBYZWHAPXIJID-UHFFFAOYSA-N 0.000 description 1
• WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
• DIOHEXPTUTVCNX-UHFFFAOYSA-N 1,1,1-trifluoro-n-phenyl-n-(trifluoromethylsulfonyl)methanesulfonamide Chemical compound FC(F)(F)S(=O)(=O)N(S(=O)(=O)C(F)(F)F)C1=CC=CC=C1 DIOHEXPTUTVCNX-UHFFFAOYSA-N 0.000 description 1
• PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 1
• NSGLGHBAIYZQIN-UHFFFAOYSA-N 1,6-dimethyl-2-oxo-5-[3-(trifluoromethoxy)phenyl]pyridine-3-carbonitrile Chemical compound C1=C(C#N)C(=O)N(C)C(C)=C1C1=CC=CC(OC(F)(F)F)=C1 NSGLGHBAIYZQIN-UHFFFAOYSA-N 0.000 description 1
• MHVYAPBQATYMIY-UHFFFAOYSA-N 1-(3-chlorophenyl)-6-methyl-4-oxopyridine-3-carbonitrile Chemical compound CC1=CC(=O)C(C#N)=CN1C1=CC=CC(Cl)=C1 MHVYAPBQATYMIY-UHFFFAOYSA-N 0.000 description 1
• YKUHMBCPMXMGSW-UHFFFAOYSA-N 1-(3-chlorophenyl)-6-methyl-4-oxopyridine-3-carboxylic acid Chemical compound CC1=CC(=O)C(C(O)=O)=CN1C1=CC=CC(Cl)=C1 YKUHMBCPMXMGSW-UHFFFAOYSA-N 0.000 description 1
• NHDOHTQSXMMAPT-UHFFFAOYSA-N 1-(bromomethyl)-4-chloro-2-iodobenzene Chemical compound ClC1=CC=C(CBr)C(I)=C1 NHDOHTQSXMMAPT-UHFFFAOYSA-N 0.000 description 1
• CYNYIHKIEHGYOZ-UHFFFAOYSA-N 1-bromopropane Chemical compound CCCBr CYNYIHKIEHGYOZ-UHFFFAOYSA-N 0.000 description 1
• JMLWXCJXOYDXRN-UHFFFAOYSA-N 1-chloro-3-iodobenzene Chemical compound ClC1=CC=CC(I)=C1 JMLWXCJXOYDXRN-UHFFFAOYSA-N 0.000 description 1
• VFWCMGCRMGJXDK-UHFFFAOYSA-N 1-chlorobutane Chemical class CCCCCl VFWCMGCRMGJXDK-UHFFFAOYSA-N 0.000 description 1
• MCTWTZJPVLRJOU-UHFFFAOYSA-N 1-methyl-1H-imidazole Chemical compound CN1C=CN=C1 MCTWTZJPVLRJOU-UHFFFAOYSA-N 0.000 description 1
• YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
• YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 1
• LXFQSRIDYRFTJW-UHFFFAOYSA-M 2,4,6-trimethylbenzenesulfonate Chemical compound CC1=CC(C)=C(S([O-])(=O)=O)C(C)=C1 LXFQSRIDYRFTJW-UHFFFAOYSA-M 0.000 description 1
• UEJJHQNACJXSKW-UHFFFAOYSA-N 2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1C1CCC(=O)NC1=O UEJJHQNACJXSKW-UHFFFAOYSA-N 0.000 description 1
• NHFQLVZAHQRYIY-UHFFFAOYSA-N 2-(3-chlorophenyl)-6-methylpyridine-3-carbonitrile Chemical compound CC1=CC=C(C#N)C(C=2C=C(Cl)C=CC=2)=N1 NHFQLVZAHQRYIY-UHFFFAOYSA-N 0.000 description 1
• WMJAVWDCQRHFCU-UHFFFAOYSA-N 2-(3-chlorophenyl)-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC=C(C(O)=O)C(C=2C=C(Cl)C=CC=2)=N1 WMJAVWDCQRHFCU-UHFFFAOYSA-N 0.000 description 1
• NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
• PQXGRUUJIFRFGC-UHFFFAOYSA-N 2-amino-3-methylbenzonitrile Chemical compound CC1=CC=CC(C#N)=C1N PQXGRUUJIFRFGC-UHFFFAOYSA-N 0.000 description 1
• RAQYFPHUNLDWFT-UHFFFAOYSA-N 2-bromo-3-methyl-1-oxidopyridin-1-ium Chemical compound CC1=CC=C[N+]([O-])=C1Br RAQYFPHUNLDWFT-UHFFFAOYSA-N 0.000 description 1
• PZSISEFPCYMBDL-UHFFFAOYSA-N 2-bromo-3-methylpyridine Chemical compound CC1=CC=CN=C1Br PZSISEFPCYMBDL-UHFFFAOYSA-N 0.000 description 1
• FAOPPMBQNTVJBA-UHFFFAOYSA-N 2-chloro-4-(hydroxymethyl)benzonitrile Chemical compound OCC1=CC=C(C#N)C(Cl)=C1 FAOPPMBQNTVJBA-UHFFFAOYSA-N 0.000 description 1
• STILRAGYCPZICJ-UHFFFAOYSA-N 2-chloro-4-[hydroxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound CN1C=NC=C1C(O)C1=CC=C(C#N)C(Cl)=C1 STILRAGYCPZICJ-UHFFFAOYSA-N 0.000 description 1
• GZELPDCDUYPUTD-UHFFFAOYSA-N 2-chloro-4-formylbenzonitrile Chemical compound ClC1=CC(C=O)=CC=C1C#N GZELPDCDUYPUTD-UHFFFAOYSA-N 0.000 description 1
• HLFNGYARDINCQT-UHFFFAOYSA-N 2-chloro-4-iodobenzonitrile Chemical compound ClC1=CC(I)=CC=C1C#N HLFNGYARDINCQT-UHFFFAOYSA-N 0.000 description 1
• YSBNBAYNISAUIT-UHFFFAOYSA-N 2-chloro-6-methylpyridine-3-carbonitrile Chemical compound CC1=CC=C(C#N)C(Cl)=N1 YSBNBAYNISAUIT-UHFFFAOYSA-N 0.000 description 1
• IBRSSZOHCGUTHI-UHFFFAOYSA-N 2-chloropyridine-3-carboxylic acid Chemical compound OC(=O)C1=CC=CN=C1Cl IBRSSZOHCGUTHI-UHFFFAOYSA-N 0.000 description 1
• WLQHJQUGYACADR-UHFFFAOYSA-N 2-fluoro-4-(hydroxymethyl)benzonitrile Chemical compound OCC1=CC=C(C#N)C(F)=C1 WLQHJQUGYACADR-UHFFFAOYSA-N 0.000 description 1
• BVKQLNXPPQEELX-UHFFFAOYSA-N 2-fluoro-4-iodo-5-methylpyridine Chemical compound CC1=CN=C(F)C=C1I BVKQLNXPPQEELX-UHFFFAOYSA-N 0.000 description 1
• AOSOZARHUJMBLZ-UHFFFAOYSA-N 2-fluoro-5-methylpyridine Chemical compound CC1=CC=C(F)N=C1 AOSOZARHUJMBLZ-UHFFFAOYSA-N 0.000 description 1
• YEDUAINPPJYDJZ-UHFFFAOYSA-N 2-hydroxybenzothiazole Chemical compound C1=CC=C2SC(O)=NC2=C1 YEDUAINPPJYDJZ-UHFFFAOYSA-N 0.000 description 1
• XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 1
• 229940080296 2-naphthalenesulfonate Drugs 0.000 description 1
• WMPPDTMATNBGJN-UHFFFAOYSA-N 2-phenylethylbromide Chemical class BrCCC1=CC=CC=C1 WMPPDTMATNBGJN-UHFFFAOYSA-N 0.000 description 1
• 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
• LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
• MXDLOTAUUUIMMM-UHFFFAOYSA-N 3-(1,3-benzodioxol-5-yl)-4-(bromomethyl)benzonitrile Chemical compound BrCC1=CC=C(C#N)C=C1C1=CC=C(OCO2)C2=C1 MXDLOTAUUUIMMM-UHFFFAOYSA-N 0.000 description 1
• TVHKJRWXXDEDOH-UHFFFAOYSA-N 3-(1,3-benzodioxol-5-yl)-4-(ethoxymethoxy)benzonitrile Chemical compound CCOCOC1=CC=C(C#N)C=C1C1=CC=C(OCO2)C2=C1 TVHKJRWXXDEDOH-UHFFFAOYSA-N 0.000 description 1
• UNAOPZLXEOWROD-UHFFFAOYSA-N 3-(1,3-benzodioxol-5-yl)-4-[2-(4-cyanophenyl)-2-fluoro-2-(3-methylimidazol-4-yl)ethoxy]benzonitrile Chemical compound CN1C=NC=C1C(F)(C=1C=CC(=CC=1)C#N)COC1=CC=C(C#N)C=C1C1=CC=C(OCO2)C2=C1 UNAOPZLXEOWROD-UHFFFAOYSA-N 0.000 description 1
• SBPRIBWXRMTHGP-UHFFFAOYSA-N 3-(1,3-benzodioxol-5-yl)-4-[2-(4-cyanophenyl)-2-oxoethoxy]benzonitrile Chemical compound C=1C=C(C#N)C=C(C=2C=C3OCOC3=CC=2)C=1OCC(=O)C1=CC=C(C#N)C=C1 SBPRIBWXRMTHGP-UHFFFAOYSA-N 0.000 description 1
• WHIWQBFLXBITBR-UHFFFAOYSA-N 3-(1,3-benzodioxol-5-yl)-4-hydroxybenzonitrile Chemical compound OC1=CC=C(C#N)C=C1C1=CC=C(OCO2)C2=C1 WHIWQBFLXBITBR-UHFFFAOYSA-N 0.000 description 1
• IVUKBVPHHDDYQG-UHFFFAOYSA-N 3-(1,3-benzodioxol-5-yl)-4-methylbenzonitrile Chemical compound CC1=CC=C(C#N)C=C1C1=CC=C(OCO2)C2=C1 IVUKBVPHHDDYQG-UHFFFAOYSA-N 0.000 description 1
• QJOWHMRFPXUONT-UHFFFAOYSA-N 3-(2,2-difluoro-1,3-benzodioxol-5-yl)-4-hydroxybenzonitrile Chemical compound OC1=CC=C(C#N)C=C1C1=CC=C(OC(F)(F)O2)C2=C1 QJOWHMRFPXUONT-UHFFFAOYSA-N 0.000 description 1
• YVDWXQVDRBSMST-UHFFFAOYSA-N 3-(3,4-dichlorophenyl)-4-hydroxybenzonitrile Chemical compound OC1=CC=C(C#N)C=C1C1=CC=C(Cl)C(Cl)=C1 YVDWXQVDRBSMST-UHFFFAOYSA-N 0.000 description 1
• BUVJKDQMCSINIH-UHFFFAOYSA-N 3-(3,4-difluorophenyl)-4-hydroxybenzonitrile Chemical compound OC1=CC=C(C#N)C=C1C1=CC=C(F)C(F)=C1 BUVJKDQMCSINIH-UHFFFAOYSA-N 0.000 description 1
• NYKVRXBJAIXDQY-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)-4-hydroxybenzonitrile Chemical compound OC1=CC=C(C#N)C=C1C1=CC(Cl)=CC(Cl)=C1 NYKVRXBJAIXDQY-UHFFFAOYSA-N 0.000 description 1
• OUPIQLZXOOQXQH-UHFFFAOYSA-N 3-(3,5-difluorophenyl)-4-hydroxybenzonitrile Chemical compound OC1=CC=C(C#N)C=C1C1=CC(F)=CC(F)=C1 OUPIQLZXOOQXQH-UHFFFAOYSA-N 0.000 description 1
• PZLIDEYPLSJOBU-UHFFFAOYSA-N 3-(3-chloro-4-fluorophenyl)-4-[2-(4-cyanophenyl)-2-hydroxy-2-(3-methylimidazol-4-yl)ethoxy]benzonitrile Chemical compound CN1C=NC=C1C(O)(C=1C=CC(=CC=1)C#N)COC1=CC=C(C#N)C=C1C1=CC=C(F)C(Cl)=C1 PZLIDEYPLSJOBU-UHFFFAOYSA-N 0.000 description 1
• UZTBOAIHHNASCU-UHFFFAOYSA-N 3-(3-chloro-4-fluorophenyl)-4-[2-(4-cyanophenyl)-2-oxoethoxy]benzonitrile Chemical compound C1=C(Cl)C(F)=CC=C1C1=CC(C#N)=CC=C1OCC(=O)C1=CC=C(C#N)C=C1 UZTBOAIHHNASCU-UHFFFAOYSA-N 0.000 description 1
• VHMDGKSOAGQKAH-UHFFFAOYSA-N 3-(3-chlorophenyl)-4-(hydroxymethyl)benzonitrile Chemical compound OCC1=CC=C(C#N)C=C1C1=CC=CC(Cl)=C1 VHMDGKSOAGQKAH-UHFFFAOYSA-N 0.000 description 1
• MQDAJUJBXNZJQP-UHFFFAOYSA-N 3-(3-chlorophenyl)-4-[2-(4-cyanophenyl)-2-fluoro-2-(3-methylimidazol-4-yl)ethoxy]benzonitrile Chemical compound CN1C=NC=C1C(F)(C=1C=CC(=CC=1)C#N)COC1=CC=C(C#N)C=C1C1=CC=CC(Cl)=C1 MQDAJUJBXNZJQP-UHFFFAOYSA-N 0.000 description 1
• JCGNNAZBMQAMJM-UHFFFAOYSA-N 3-(3-chlorophenyl)-4-[2-(4-cyanophenyl)-2-oxoethoxy]benzonitrile Chemical compound ClC1=CC=CC(C=2C(=CC=C(C=2)C#N)OCC(=O)C=2C=CC(=CC=2)C#N)=C1 JCGNNAZBMQAMJM-UHFFFAOYSA-N 0.000 description 1
• WOQDLBMUBVDSFE-UHFFFAOYSA-N 3-(3-fluorophenyl)-4-hydroxybenzonitrile Chemical compound OC1=CC=C(C#N)C=C1C1=CC=CC(F)=C1 WOQDLBMUBVDSFE-UHFFFAOYSA-N 0.000 description 1
• JZWPZBVCHCUQFE-UHFFFAOYSA-N 3-(3-methoxyphenyl)-4-(methylamino)benzonitrile Chemical compound CNC1=CC=C(C#N)C=C1C1=CC=CC(OC)=C1 JZWPZBVCHCUQFE-UHFFFAOYSA-N 0.000 description 1
• UQZZTKHIPGLXBP-UHFFFAOYSA-N 3-(bromomethyl)-2-(3-chlorophenyl)-6-methylpyridine Chemical compound CC1=CC=C(CBr)C(C=2C=C(Cl)C=CC=2)=N1 UQZZTKHIPGLXBP-UHFFFAOYSA-N 0.000 description 1
• VFAVAINSESIKTQ-UHFFFAOYSA-N 3-(bromomethyl)-6-chloro-2-(3-chlorophenyl)pyridine Chemical compound ClC1=CC=CC(C=2C(=CC=C(Cl)N=2)CBr)=C1 VFAVAINSESIKTQ-UHFFFAOYSA-N 0.000 description 1
• RETKPFTZUHXYTM-UHFFFAOYSA-N 3-[5-chloro-2-[[(4-cyanophenyl)-(3-methylimidazol-4-yl)methoxy]methyl]phenyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=CC=C(Cl)C=C1C1=CC=CC(C#N)=C1 RETKPFTZUHXYTM-UHFFFAOYSA-N 0.000 description 1
• GFWBKUDRXMQSFD-FJXQXJEOSA-M 3-aminopropanoyl-[(1s)-1-carboxy-2-(1h-imidazol-5-yl)ethyl]azanide;zinc Chemical compound [Zn].NCCC(=O)[N-][C@H](C(O)=O)CC1=CN=CN1 GFWBKUDRXMQSFD-FJXQXJEOSA-M 0.000 description 1
• VVHDDZBKOSMCJY-UHFFFAOYSA-N 3-bromo-4-[2-(4-cyanophenyl)-2-hydroxy-2-(3-methylimidazol-4-yl)ethoxy]benzonitrile Chemical compound CN1C=NC=C1C(O)(C=1C=CC(=CC=1)C#N)COC1=CC=C(C#N)C=C1Br VVHDDZBKOSMCJY-UHFFFAOYSA-N 0.000 description 1
• HLHNOIAOWQFNGW-UHFFFAOYSA-N 3-bromo-4-hydroxybenzonitrile Chemical compound OC1=CC=C(C#N)C=C1Br HLHNOIAOWQFNGW-UHFFFAOYSA-N 0.000 description 1
• MWVIHOPQURQBCL-UHFFFAOYSA-N 3-chloro-4-(methylamino)benzonitrile Chemical compound CNC1=CC=C(C#N)C=C1Cl MWVIHOPQURQBCL-UHFFFAOYSA-N 0.000 description 1
• VAHXXQJJZKBZDX-UHFFFAOYSA-N 3-chloro-4-fluorobenzonitrile Chemical compound FC1=CC=C(C#N)C=C1Cl VAHXXQJJZKBZDX-UHFFFAOYSA-N 0.000 description 1
• PNPCRKVUWYDDST-UHFFFAOYSA-N 3-chloroaniline Chemical compound NC1=CC=CC(Cl)=C1 PNPCRKVUWYDDST-UHFFFAOYSA-N 0.000 description 1
• YGAURRAHPYQHDC-UHFFFAOYSA-N 3-fluoro-4-(hydroxymethyl)benzonitrile Chemical compound OCC1=CC=C(C#N)C=C1F YGAURRAHPYQHDC-UHFFFAOYSA-N 0.000 description 1
• BLPIJOVBXLGHFM-UHFFFAOYSA-N 3-fluoro-4-[hydroxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound CN1C=NC=C1C(O)C1=CC=C(C#N)C=C1F BLPIJOVBXLGHFM-UHFFFAOYSA-N 0.000 description 1
• QXHUSGWCFSXQMF-UHFFFAOYSA-N 3-fluoro-4-formylbenzonitrile Chemical compound FC1=CC(C#N)=CC=C1C=O QXHUSGWCFSXQMF-UHFFFAOYSA-N 0.000 description 1
• KUQQONVKIURIQU-UHFFFAOYSA-N 3-fluoro-4-methylbenzonitrile Chemical group CC1=CC=C(C#N)C=C1F KUQQONVKIURIQU-UHFFFAOYSA-N 0.000 description 1
• YGXPQBKQVKASBM-UHFFFAOYSA-N 3-iodo-4-methylbenzonitrile Chemical compound CC1=CC=C(C#N)C=C1I YGXPQBKQVKASBM-UHFFFAOYSA-N 0.000 description 1
• XMIIGOLPHOKFCH-UHFFFAOYSA-M 3-phenylpropionate Chemical compound [O-]C(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-M 0.000 description 1
• LJANCPRIUMHGJE-UHFFFAOYSA-N 4-(2-bromoacetyl)benzonitrile Chemical compound BrCC(=O)C1=CC=C(C#N)C=C1 LJANCPRIUMHGJE-UHFFFAOYSA-N 0.000 description 1
• VURVUZOPTNCTNX-UHFFFAOYSA-N 4-(3-chlorophenyl)-1-methyl-6-oxopyridine-3-carboxylic acid Chemical compound O=C1N(C)C=C(C(O)=O)C(C=2C=C(Cl)C=CC=2)=C1 VURVUZOPTNCTNX-UHFFFAOYSA-N 0.000 description 1
• VFIMBCCSSLGIAH-UHFFFAOYSA-N 4-(3-chlorophenyl)-2-fluoro-5-methylpyridine Chemical compound CC1=CN=C(F)C=C1C1=CC=CC(Cl)=C1 VFIMBCCSSLGIAH-UHFFFAOYSA-N 0.000 description 1
• JSOBOJFAZXPIFV-UHFFFAOYSA-N 4-(3-chlorophenyl)-5-[[(4-cyanophenyl)-(3-methylimidazol-4-yl)methoxy]methyl]pyridine-2-carbonitrile Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=CN=C(C#N)C=C1C1=CC=CC(Cl)=C1 JSOBOJFAZXPIFV-UHFFFAOYSA-N 0.000 description 1
• CYPJNNGTWORXSU-UHFFFAOYSA-N 4-(3-chlorophenyl)-5-methylpyridine-2-carbonitrile Chemical compound CC1=CN=C(C#N)C=C1C1=CC=CC(Cl)=C1 CYPJNNGTWORXSU-UHFFFAOYSA-N 0.000 description 1
• YYLHZLOUPLZTDX-UHFFFAOYSA-N 4-(3-methylimidazole-4-carbonyl)benzonitrile Chemical compound CN1C=NC=C1C(=O)C1=CC=C(C#N)C=C1 YYLHZLOUPLZTDX-UHFFFAOYSA-N 0.000 description 1
• GDYYQNQZTANDAY-UHFFFAOYSA-N 4-(bromomethyl)-3-(3-chlorophenyl)benzonitrile Chemical compound ClC1=CC=CC(C=2C(=CC=C(C=2)C#N)CBr)=C1 GDYYQNQZTANDAY-UHFFFAOYSA-N 0.000 description 1
• JKKIZRDYJSNNKN-UHFFFAOYSA-N 4-(bromomethyl)-3-(3-ethoxyphenyl)benzonitrile Chemical compound CCOC1=CC=CC(C=2C(=CC=C(C=2)C#N)CBr)=C1 JKKIZRDYJSNNKN-UHFFFAOYSA-N 0.000 description 1
• JIOXAYVJWXFSFW-UHFFFAOYSA-N 4-(bromomethyl)-3-(3-methoxyphenyl)benzonitrile Chemical compound COC1=CC=CC(C=2C(=CC=C(C=2)C#N)CBr)=C1 JIOXAYVJWXFSFW-UHFFFAOYSA-N 0.000 description 1
• ZESZAIOGACKOMB-UHFFFAOYSA-N 4-(bromomethyl)-3-fluorobenzonitrile Chemical compound FC1=CC(C#N)=CC=C1CBr ZESZAIOGACKOMB-UHFFFAOYSA-N 0.000 description 1
• WTPXWARAYTYZIY-UHFFFAOYSA-N 4-(bromomethyl)-3-iodobenzonitrile Chemical compound BrCC1=CC=C(C#N)C=C1I WTPXWARAYTYZIY-UHFFFAOYSA-N 0.000 description 1
• WRUKKUVTBNVMMD-UHFFFAOYSA-N 4-(ethoxymethoxy)-3-(3-fluorophenyl)benzonitrile Chemical compound CCOCOC1=CC=C(C#N)C=C1C1=CC=CC(F)=C1 WRUKKUVTBNVMMD-UHFFFAOYSA-N 0.000 description 1
• GMOJNFANBQZRLK-UHFFFAOYSA-N 4-(ethoxymethoxy)-3-(3-methoxyphenyl)benzonitrile Chemical compound CCOCOC1=CC=C(C#N)C=C1C1=CC=CC(OC)=C1 GMOJNFANBQZRLK-UHFFFAOYSA-N 0.000 description 1
• DLNKQOWDDKKQGL-UHFFFAOYSA-N 4-(ethoxymethoxy)-3-[4-(trifluoromethoxy)phenyl]benzonitrile Chemical compound CCOCOC1=CC=C(C#N)C=C1C1=CC=C(OC(F)(F)F)C=C1 DLNKQOWDDKKQGL-UHFFFAOYSA-N 0.000 description 1
• UWRKSBQGKQPCOG-UHFFFAOYSA-N 4-(ethoxymethoxy)-3-naphthalen-1-ylbenzonitrile Chemical compound CCOCOC1=CC=C(C#N)C=C1C1=CC=CC2=CC=CC=C12 UWRKSBQGKQPCOG-UHFFFAOYSA-N 0.000 description 1
• LQAZQSSPKNVZLK-UHFFFAOYSA-N 4-(ethoxymethoxy)-3-quinolin-8-ylbenzonitrile Chemical compound CCOCOC1=CC=C(C#N)C=C1C1=CC=CC2=CC=CN=C12 LQAZQSSPKNVZLK-UHFFFAOYSA-N 0.000 description 1
• PJFNTVKYLRMWKI-UHFFFAOYSA-N 4-[(2-amino-4-iodophenyl)methoxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=CC=C(I)C=C1N PJFNTVKYLRMWKI-UHFFFAOYSA-N 0.000 description 1
• DCKQBCSHQPZIIS-UHFFFAOYSA-N 4-[(4-chloro-2-iodophenyl)methoxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=CC=C(Cl)C=C1I DCKQBCSHQPZIIS-UHFFFAOYSA-N 0.000 description 1
• MFCMXPRNVRITDB-UHFFFAOYSA-N 4-[(4-chloro-2-naphthalen-1-ylphenyl)methoxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=CC=C(Cl)C=C1C1=CC=CC2=CC=CC=C12 MFCMXPRNVRITDB-UHFFFAOYSA-N 0.000 description 1
• YQNSABFGOXFPJU-UHFFFAOYSA-N 4-[1,2-dihydroxy-1-(3-methylimidazol-4-yl)ethyl]benzonitrile Chemical compound CN1C=NC=C1C(O)(CO)C1=CC=C(C#N)C=C1 YQNSABFGOXFPJU-UHFFFAOYSA-N 0.000 description 1
• CQWWSZPAORZPIH-UHFFFAOYSA-N 4-[2-(3-methylimidazol-4-yl)oxiran-2-yl]benzonitrile Chemical compound CN1C=NC=C1C1(C=2C=CC(=CC=2)C#N)OC1 CQWWSZPAORZPIH-UHFFFAOYSA-N 0.000 description 1
• PKQUJSQTFQLZJE-UHFFFAOYSA-N 4-[2-(4-cyanophenyl)-2-fluoro-2-(3-methylimidazol-4-yl)ethoxy]-3-(3,4-dichlorophenyl)benzonitrile Chemical compound CN1C=NC=C1C(F)(C=1C=CC(=CC=1)C#N)COC1=CC=C(C#N)C=C1C1=CC=C(Cl)C(Cl)=C1 PKQUJSQTFQLZJE-UHFFFAOYSA-N 0.000 description 1
• FTGPQXVJCFDIRA-UHFFFAOYSA-N 4-[2-(4-cyanophenyl)-2-fluoro-2-(3-methylimidazol-4-yl)ethoxy]-3-(3,4-difluorophenyl)benzonitrile Chemical compound CN1C=NC=C1C(F)(C=1C=CC(=CC=1)C#N)COC1=CC=C(C#N)C=C1C1=CC=C(F)C(F)=C1 FTGPQXVJCFDIRA-UHFFFAOYSA-N 0.000 description 1
• OZYJQMRRBFQKNP-UHFFFAOYSA-N 4-[2-(4-cyanophenyl)-2-fluoro-2-(3-methylimidazol-4-yl)ethoxy]-3-(3,5-dichlorophenyl)benzonitrile Chemical compound CN1C=NC=C1C(F)(C=1C=CC(=CC=1)C#N)COC1=CC=C(C#N)C=C1C1=CC(Cl)=CC(Cl)=C1 OZYJQMRRBFQKNP-UHFFFAOYSA-N 0.000 description 1
• RGLMNAZFZRKICV-UHFFFAOYSA-N 4-[2-(4-cyanophenyl)-2-fluoro-2-(3-methylimidazol-4-yl)ethoxy]-3-(3,5-difluorophenyl)benzonitrile Chemical compound CN1C=NC=C1C(F)(C=1C=CC(=CC=1)C#N)COC1=CC=C(C#N)C=C1C1=CC(F)=CC(F)=C1 RGLMNAZFZRKICV-UHFFFAOYSA-N 0.000 description 1
• PWSRTFMUURLVJK-UHFFFAOYSA-N 4-[2-(4-cyanophenyl)-2-fluoro-2-(3-methylimidazol-4-yl)ethoxy]-3-(3-methoxyphenyl)benzonitrile Chemical compound COC1=CC=CC(C=2C(=CC=C(C=2)C#N)OCC(F)(C=2N(C=NC=2)C)C=2C=CC(=CC=2)C#N)=C1 PWSRTFMUURLVJK-UHFFFAOYSA-N 0.000 description 1
• ZAOQDHQGYOCRTF-UHFFFAOYSA-N 4-[2-(4-cyanophenyl)-2-hydroxy-2-(3-methylimidazol-4-yl)ethoxy]-3-(2,2-difluoro-1,3-benzodioxol-5-yl)benzonitrile Chemical compound CN1C=NC=C1C(O)(C=1C=CC(=CC=1)C#N)COC1=CC=C(C#N)C=C1C1=CC=C(OC(F)(F)O2)C2=C1 ZAOQDHQGYOCRTF-UHFFFAOYSA-N 0.000 description 1
• HMOPLOQUVROBNS-UHFFFAOYSA-N 4-[2-(4-cyanophenyl)-2-hydroxy-2-(3-methylimidazol-4-yl)ethoxy]-3-(3,5-dichlorophenyl)benzonitrile Chemical compound CN1C=NC=C1C(O)(C=1C=CC(=CC=1)C#N)COC1=CC=C(C#N)C=C1C1=CC(Cl)=CC(Cl)=C1 HMOPLOQUVROBNS-UHFFFAOYSA-N 0.000 description 1
• BYMFNTIBPMRLIN-UHFFFAOYSA-N 4-[2-(4-cyanophenyl)-2-hydroxy-2-(3-methylimidazol-4-yl)ethoxy]-3-(3,5-difluorophenyl)benzonitrile Chemical compound CN1C=NC=C1C(O)(C=1C=CC(=CC=1)C#N)COC1=CC=C(C#N)C=C1C1=CC(F)=CC(F)=C1 BYMFNTIBPMRLIN-UHFFFAOYSA-N 0.000 description 1
• QRKZRZUNTFVGFR-UHFFFAOYSA-N 4-[2-(4-cyanophenyl)-2-hydroxy-2-(3-methylimidazol-4-yl)ethoxy]-3-[3-(trifluoromethoxy)phenyl]benzonitrile Chemical compound CN1C=NC=C1C(O)(C=1C=CC(=CC=1)C#N)COC1=CC=C(C#N)C=C1C1=CC=CC(OC(F)(F)F)=C1 QRKZRZUNTFVGFR-UHFFFAOYSA-N 0.000 description 1
• HEUVRFNVTLGKMZ-UHFFFAOYSA-N 4-[2-(4-cyanophenyl)-2-hydroxy-2-(3-methylimidazol-4-yl)ethoxy]-3-[4-(trifluoromethoxy)phenyl]benzonitrile Chemical compound CN1C=NC=C1C(O)(C=1C=CC(=CC=1)C#N)COC1=CC=C(C#N)C=C1C1=CC=C(OC(F)(F)F)C=C1 HEUVRFNVTLGKMZ-UHFFFAOYSA-N 0.000 description 1
• CPMSWKFJKMDFAL-UHFFFAOYSA-N 4-[2-(4-cyanophenyl)-2-hydroxy-2-(3-methylimidazol-4-yl)ethoxy]-3-naphthalen-1-ylbenzonitrile Chemical compound CN1C=NC=C1C(O)(C=1C=CC(=CC=1)C#N)COC1=CC=C(C#N)C=C1C1=CC=CC2=CC=CC=C12 CPMSWKFJKMDFAL-UHFFFAOYSA-N 0.000 description 1
• WEOLXCVAXKWGLC-UHFFFAOYSA-N 4-[2-(4-cyanophenyl)-2-oxoethoxy]-3-(2,2-difluoro-1,3-benzodioxol-5-yl)benzonitrile Chemical compound C1=C2OC(F)(F)OC2=CC=C1C1=CC(C#N)=CC=C1OCC(=O)C1=CC=C(C#N)C=C1 WEOLXCVAXKWGLC-UHFFFAOYSA-N 0.000 description 1
• AQZJVPXRZLQGMT-UHFFFAOYSA-N 4-[2-(4-cyanophenyl)-2-oxoethoxy]-3-(3-fluorophenyl)benzonitrile Chemical compound FC1=CC=CC(C=2C(=CC=C(C=2)C#N)OCC(=O)C=2C=CC(=CC=2)C#N)=C1 AQZJVPXRZLQGMT-UHFFFAOYSA-N 0.000 description 1
• SBXWSTVEDJUWJE-UHFFFAOYSA-N 4-[2-(4-cyanophenyl)-2-oxoethoxy]-3-(3-methoxyphenyl)benzonitrile Chemical compound COC1=CC=CC(C=2C(=CC=C(C=2)C#N)OCC(=O)C=2C=CC(=CC=2)C#N)=C1 SBXWSTVEDJUWJE-UHFFFAOYSA-N 0.000 description 1
• RCLDZDGKYBUTKG-UHFFFAOYSA-N 4-[2-(4-cyanophenyl)-2-oxoethoxy]-3-naphthalen-1-ylbenzonitrile Chemical compound C=1C=C(C#N)C=C(C=2C3=CC=CC=C3C=CC=2)C=1OCC(=O)C1=CC=C(C#N)C=C1 RCLDZDGKYBUTKG-UHFFFAOYSA-N 0.000 description 1
• KGPOTHWSSUINBY-UHFFFAOYSA-N 4-[2-(4-cyanophenyl)-2-oxoethoxy]-3-quinolin-8-ylbenzonitrile Chemical compound C=1C=C(C#N)C=C(C=2C3=NC=CC=C3C=CC=2)C=1OCC(=O)C1=CC=C(C#N)C=C1 KGPOTHWSSUINBY-UHFFFAOYSA-N 0.000 description 1
• AYVGITDSDRJQKI-UHFFFAOYSA-N 4-[3-[4-chloro-2-(3-chlorophenyl)phenyl]-1-hydroxy-1-(3-methylimidazol-4-yl)prop-2-ynyl]benzonitrile Chemical compound CN1C=NC=C1C(O)(C=1C=CC(=CC=1)C#N)C#CC1=CC=C(Cl)C=C1C1=CC=CC(Cl)=C1 AYVGITDSDRJQKI-UHFFFAOYSA-N 0.000 description 1
• DQULASPPLJLHJJ-UHFFFAOYSA-N 4-[[(4-cyanophenyl)-(3-methylimidazol-4-yl)methoxy]methyl]-3-(3-ethoxyphenyl)benzonitrile Chemical compound CCOC1=CC=CC(C=2C(=CC=C(C=2)C#N)COC(C=2N(C=NC=2)C)C=2C=CC(=CC=2)C#N)=C1 DQULASPPLJLHJJ-UHFFFAOYSA-N 0.000 description 1
• QQZYKSKGVSDVOW-UHFFFAOYSA-N 4-[[(4-cyanophenyl)-(3-methylimidazol-4-yl)methoxy]methyl]-3-(3-methoxyphenyl)benzonitrile Chemical compound COC1=CC=CC(C=2C(=CC=C(C=2)C#N)COC(C=2N(C=NC=2)C)C=2C=CC(=CC=2)C#N)=C1 QQZYKSKGVSDVOW-UHFFFAOYSA-N 0.000 description 1
• HJQPATRUMRMWDT-UHFFFAOYSA-N 4-[[(4-cyanophenyl)-(3-methylimidazol-4-yl)methoxy]methyl]-3-(6-propoxypyridin-3-yl)benzonitrile Chemical compound C1=NC(OCCC)=CC=C1C1=CC(C#N)=CC=C1COC(C=1C=CC(=CC=1)C#N)C1=CN=CN1C HJQPATRUMRMWDT-UHFFFAOYSA-N 0.000 description 1
• ASEIFCMLBQCEBW-UHFFFAOYSA-N 4-[[2-(1,3-benzodioxol-5-yl)-4-chlorophenyl]methoxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=CC=C(Cl)C=C1C1=CC=C(OCO2)C2=C1 ASEIFCMLBQCEBW-UHFFFAOYSA-N 0.000 description 1
• GZJDKJUMNDCQKD-UHFFFAOYSA-N 4-[[2-(2-acetylphenyl)-4-chlorophenyl]methoxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound CC(=O)C1=CC=CC=C1C1=CC(Cl)=CC=C1COC(C=1C=CC(=CC=1)C#N)C1=CN=CN1C GZJDKJUMNDCQKD-UHFFFAOYSA-N 0.000 description 1
• LWVLBSXYDMIWBM-UHFFFAOYSA-N 4-[[2-(3-aminophenyl)-4-chlorophenyl]methoxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=CC=C(Cl)C=C1C1=CC=CC(N)=C1 LWVLBSXYDMIWBM-UHFFFAOYSA-N 0.000 description 1
• GPEAZYSALHMHOV-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-6-methylpyridin-3-yl]methoxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound C=1C=CC(Cl)=CC=1C1=NC(C)=CC=C1COC(C=1C=CC(=CC=1)C#N)C1=CN=CN1C GPEAZYSALHMHOV-UHFFFAOYSA-N 0.000 description 1
• CWDYZMAQHDNKLH-UHFFFAOYSA-N 4-[[2-(4-cyanophenyl)-2-hydroxy-2-(3-methylimidazol-4-yl)ethyl]-methylamino]-3-(3-methoxyphenyl)benzonitrile Chemical compound COC1=CC=CC(C=2C(=CC=C(C=2)C#N)N(C)CC(O)(C=2N(C=NC=2)C)C=2C=CC(=CC=2)C#N)=C1 CWDYZMAQHDNKLH-UHFFFAOYSA-N 0.000 description 1
• XLLVBPBNRUBQEM-UHFFFAOYSA-N 4-[[2-(4-tert-butylphenyl)-4-chlorophenyl]methoxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=CC=C(Cl)C=C1C1=CC=C(C(C)(C)C)C=C1 XLLVBPBNRUBQEM-UHFFFAOYSA-N 0.000 description 1
• WEAJYVSCHBORSM-UHFFFAOYSA-N 4-[[4-(3-chlorophenyl)-6-fluoropyridin-3-yl]methoxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=CN=C(F)C=C1C1=CC=CC(Cl)=C1 WEAJYVSCHBORSM-UHFFFAOYSA-N 0.000 description 1
• VMDNGBUGIGZHTQ-UHFFFAOYSA-N 4-[[4-chloro-2-(2,3-dichlorophenyl)phenyl]methoxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=CC=C(Cl)C=C1C1=CC=CC(Cl)=C1Cl VMDNGBUGIGZHTQ-UHFFFAOYSA-N 0.000 description 1
• AQYBOUFJQQDPJL-UHFFFAOYSA-N 4-[[4-chloro-2-(2,5-dimethoxyphenyl)phenyl]methoxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound COC1=CC=C(OC)C(C=2C(=CC=C(Cl)C=2)COC(C=2N(C=NC=2)C)C=2C=CC(=CC=2)C#N)=C1 AQYBOUFJQQDPJL-UHFFFAOYSA-N 0.000 description 1
• GPVOQWAYDISNNG-UHFFFAOYSA-N 4-[[4-chloro-2-(2-chlorophenyl)phenyl]methoxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=CC=C(Cl)C=C1C1=CC=CC=C1Cl GPVOQWAYDISNNG-UHFFFAOYSA-N 0.000 description 1
• ZZINPFFYPIDZDN-UHFFFAOYSA-N 4-[[4-chloro-2-(3,4-dimethoxyphenyl)phenyl]methoxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC(Cl)=CC=C1COC(C=1C=CC(=CC=1)C#N)C1=CN=CN1C ZZINPFFYPIDZDN-UHFFFAOYSA-N 0.000 description 1
• ZMXXEKNDTIYVTK-UHFFFAOYSA-N 4-[[4-chloro-2-(3,4-dimethylphenyl)phenyl]methoxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound C1=C(C)C(C)=CC=C1C1=CC(Cl)=CC=C1COC(C=1C=CC(=CC=1)C#N)C1=CN=CN1C ZMXXEKNDTIYVTK-UHFFFAOYSA-N 0.000 description 1
• BGTSWQBYLRXEOF-UHFFFAOYSA-N 4-[[4-chloro-2-(3,5-dichlorophenyl)phenyl]methoxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=CC=C(Cl)C=C1C1=CC(Cl)=CC(Cl)=C1 BGTSWQBYLRXEOF-UHFFFAOYSA-N 0.000 description 1
• BHZQJRLCCBRETP-UHFFFAOYSA-N 4-[[4-chloro-2-(3-chlorophenyl)phenyl]methoxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=CC=C(Cl)C=C1C1=CC=CC(Cl)=C1 BHZQJRLCCBRETP-UHFFFAOYSA-N 0.000 description 1
• BXKCFYNBNACCKW-UHFFFAOYSA-N 4-[[4-chloro-2-(3-ethoxyphenyl)phenyl]methoxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound CCOC1=CC=CC(C=2C(=CC=C(Cl)C=2)COC(C=2N(C=NC=2)C)C=2C=CC(=CC=2)C#N)=C1 BXKCFYNBNACCKW-UHFFFAOYSA-N 0.000 description 1
• IHVQQYNDDVDCAY-UHFFFAOYSA-N 4-[[4-chloro-2-(3-fluorophenyl)phenyl]methoxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=CC=C(Cl)C=C1C1=CC=CC(F)=C1 IHVQQYNDDVDCAY-UHFFFAOYSA-N 0.000 description 1
• HNIALKMXDHGPES-UHFFFAOYSA-N 4-[[4-chloro-2-(3-formylphenyl)phenyl]methoxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=CC=C(Cl)C=C1C1=CC=CC(C=O)=C1 HNIALKMXDHGPES-UHFFFAOYSA-N 0.000 description 1
• XLJZOXQSQVYZNS-UHFFFAOYSA-N 4-[[4-chloro-2-(3-methoxyphenyl)phenyl]methoxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound COC1=CC=CC(C=2C(=CC=C(Cl)C=2)COC(C=2N(C=NC=2)C)C=2C=CC(=CC=2)C#N)=C1 XLJZOXQSQVYZNS-UHFFFAOYSA-N 0.000 description 1
• ZAHXZFMDVQAAGF-UHFFFAOYSA-N 4-[[4-chloro-2-(5-formylthiophen-2-yl)phenyl]methoxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=CC=C(Cl)C=C1C1=CC=C(C=O)S1 ZAHXZFMDVQAAGF-UHFFFAOYSA-N 0.000 description 1
• HUOOZSQGNBJFRN-UHFFFAOYSA-N 4-[[4-chloro-2-[3-(trifluoromethyl)phenyl]phenyl]methoxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=CC=C(Cl)C=C1C1=CC=CC(C(F)(F)F)=C1 HUOOZSQGNBJFRN-UHFFFAOYSA-N 0.000 description 1
• QFLYQZKJFHIMOZ-UHFFFAOYSA-N 4-[[4-chloro-2-[4-(trifluoromethyl)phenyl]phenyl]methoxy-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=CC=C(Cl)C=C1C1=CC=C(C(F)(F)F)C=C1 QFLYQZKJFHIMOZ-UHFFFAOYSA-N 0.000 description 1
• YEZXZWFJRVJENB-UHFFFAOYSA-N 4-[amino-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound CN1C=NC=C1C(N)C1=CC=C(C#N)C=C1 YEZXZWFJRVJENB-UHFFFAOYSA-N 0.000 description 1
• YFFZNEYRRJRRQE-UHFFFAOYSA-N 4-[chloro-(3-methylimidazol-4-yl)methyl]benzonitrile Chemical compound CN1C=NC=C1C(Cl)C1=CC=C(C#N)C=C1 YFFZNEYRRJRRQE-UHFFFAOYSA-N 0.000 description 1
• 125000002672 4-bromobenzoyl group Chemical group BrC1=CC=C(C(=O)*)C=C1 0.000 description 1
• AAJRVZCLFKBVGN-UHFFFAOYSA-N 4-chloro-2-(3-chlorophenyl)-1-ethynylbenzene Chemical group ClC1=CC=CC(C=2C(=CC=C(Cl)C=2)C#C)=C1 AAJRVZCLFKBVGN-UHFFFAOYSA-N 0.000 description 1
• CXXXAGIYCFOGHA-UHFFFAOYSA-N 4-chloro-2-iodo-1-methoxybenzene Chemical compound COC1=CC=C(Cl)C=C1I CXXXAGIYCFOGHA-UHFFFAOYSA-N 0.000 description 1
• ZIOGCIPQDRCAKY-UHFFFAOYSA-N 4-chloro-2-iodo-1-methylbenzene Chemical compound CC1=CC=C(Cl)C=C1I ZIOGCIPQDRCAKY-UHFFFAOYSA-N 0.000 description 1
• AVPYQKSLYISFPO-HOSYLAQJSA-N 4-chlorobenzaldehyde Chemical group ClC1=CC=C([13CH]=O)C=C1 AVPYQKSLYISFPO-HOSYLAQJSA-N 0.000 description 1
• 125000000242 4-chlorobenzoyl group Chemical group ClC1=CC=C(C(=O)*)C=C1 0.000 description 1
• 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
• MBVFRSJFKMJRHA-UHFFFAOYSA-N 4-fluoro-1-benzofuran-7-carbaldehyde Chemical compound FC1=CC=C(C=O)C2=C1C=CO2 MBVFRSJFKMJRHA-UHFFFAOYSA-N 0.000 description 1
• HYVAMLOTCVMHEN-UHFFFAOYSA-N 4-fluoro-3-[4-(trifluoromethoxy)phenyl]benzonitrile Chemical compound FC1=CC=C(C#N)C=C1C1=CC=C(OC(F)(F)F)C=C1 HYVAMLOTCVMHEN-UHFFFAOYSA-N 0.000 description 1
• LUENVGYHWAWNHY-UHFFFAOYSA-N 4-hydroxy-3-(3-methoxyphenyl)benzonitrile Chemical compound COC1=CC=CC(C=2C(=CC=C(C=2)C#N)O)=C1 LUENVGYHWAWNHY-UHFFFAOYSA-N 0.000 description 1
• IPTSWINFJUSXCL-UHFFFAOYSA-N 4-hydroxy-3-[4-(trifluoromethoxy)phenyl]benzonitrile Chemical compound OC1=CC=C(C#N)C=C1C1=CC=C(OC(F)(F)F)C=C1 IPTSWINFJUSXCL-UHFFFAOYSA-N 0.000 description 1
• DORNHMUBFVMOHV-UHFFFAOYSA-N 4-hydroxy-3-naphthalen-1-ylbenzonitrile Chemical compound OC1=CC=C(C#N)C=C1C1=CC=CC2=CC=CC=C12 DORNHMUBFVMOHV-UHFFFAOYSA-N 0.000 description 1
• TWDMNDFLMKLRNR-UHFFFAOYSA-N 4-hydroxy-3-quinolin-8-ylbenzonitrile Chemical compound OC1=CC=C(C#N)C=C1C1=CC=CC2=CC=CN=C12 TWDMNDFLMKLRNR-UHFFFAOYSA-N 0.000 description 1
• QLMRDNPXYNJQMQ-UHFFFAOYSA-N 4-iodo-1-methyl-2-nitrobenzene Chemical group CC1=CC=C(I)C=C1[N+]([O-])=O QLMRDNPXYNJQMQ-UHFFFAOYSA-N 0.000 description 1
• ORLGLBZRQYOWNA-UHFFFAOYSA-N 4-methylpyridin-2-amine Chemical compound CC1=CC=NC(N)=C1 ORLGLBZRQYOWNA-UHFFFAOYSA-N 0.000 description 1
• WQBQIKICLIDOEL-UHFFFAOYSA-N 5-(3,5-difluorophenyl)-6-(hydroxymethyl)-1-methyl-2-oxopyridine-3-carbonitrile Chemical compound C1=C(C#N)C(=O)N(C)C(CO)=C1C1=CC(F)=CC(F)=C1 WQBQIKICLIDOEL-UHFFFAOYSA-N 0.000 description 1
• HFTQZNBALRDDSJ-UHFFFAOYSA-N 5-(3-chlorophenyl)-1,6-dimethyl-2-oxopyridine-3-carbonitrile Chemical compound C1=C(C#N)C(=O)N(C)C(C)=C1C1=CC=CC(Cl)=C1 HFTQZNBALRDDSJ-UHFFFAOYSA-N 0.000 description 1
• AECLAEDYDCKFJG-UHFFFAOYSA-N 5-(3-chlorophenyl)-6-[[(4-cyanophenyl)-(3-methylimidazol-4-yl)methoxy]methyl]-1-methyl-2-oxopyridine-3-carbonitrile Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=C(C=2C=C(Cl)C=CC=2)C=C(C#N)C(=O)N1C AECLAEDYDCKFJG-UHFFFAOYSA-N 0.000 description 1
• ZFYPSCFEFPGKGJ-UHFFFAOYSA-N 5-(bromomethyl)-4-(3-chlorophenyl)-2-fluoropyridine Chemical compound C1=NC(F)=CC(C=2C=C(Cl)C=CC=2)=C1CBr ZFYPSCFEFPGKGJ-UHFFFAOYSA-N 0.000 description 1
• MYUQKYGWKHTRPG-UHFFFAOYSA-N 5-bromo-2-fluoropyridine Chemical group FC1=CC=C(Br)C=N1 MYUQKYGWKHTRPG-UHFFFAOYSA-N 0.000 description 1
• XSDIDMLVJLNNNV-UHFFFAOYSA-N 5-bromo-6-methyl-2-oxo-1h-pyridine-3-carbonitrile Chemical compound CC=1NC(=O)C(C#N)=CC=1Br XSDIDMLVJLNNNV-UHFFFAOYSA-N 0.000 description 1
• PCUZCSBGJCKAIQ-UHFFFAOYSA-N 5-cyano-2-[[(4-cyanophenyl)-(3-methylimidazol-4-yl)methoxy]methyl]benzoic acid Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=CC=C(C#N)C=C1C(O)=O PCUZCSBGJCKAIQ-UHFFFAOYSA-N 0.000 description 1
• SESGKTMPPLLFGX-UHFFFAOYSA-N 6-(bromomethyl)-1-methyl-2-oxo-5-[3-(trifluoromethoxy)phenyl]pyridine-3-carbonitrile Chemical compound C1=C(C#N)C(=O)N(C)C(CBr)=C1C1=CC=CC(OC(F)(F)F)=C1 SESGKTMPPLLFGX-UHFFFAOYSA-N 0.000 description 1
• JXHDCLVDALJVKD-UHFFFAOYSA-N 6-(bromomethyl)-5-(3-chlorophenyl)-1-methyl-2-oxopyridine-3-carbonitrile Chemical compound C1=C(C#N)C(=O)N(C)C(CBr)=C1C1=CC=CC(Cl)=C1 JXHDCLVDALJVKD-UHFFFAOYSA-N 0.000 description 1
• BHKKLGROGAROGK-UHFFFAOYSA-N 6-[[(3-chloro-4-cyanophenyl)-(3-methylimidazol-4-yl)methoxy]methyl]-5-(3-chlorophenyl)-1-methyl-2-oxopyridine-3-carbonitrile Chemical compound CN1C=NC=C1C(C=1C=C(Cl)C(C#N)=CC=1)OCC1=C(C=2C=C(Cl)C=CC=2)C=C(C#N)C(=O)N1C BHKKLGROGAROGK-UHFFFAOYSA-N 0.000 description 1
• QDPDFHWHIPADBV-UHFFFAOYSA-N 6-bromo-5-(bromomethyl)pyridine-2-carbonitrile Chemical compound BrCC1=CC=C(C#N)N=C1Br QDPDFHWHIPADBV-UHFFFAOYSA-N 0.000 description 1
• DHFCAAHDNSOIAE-UHFFFAOYSA-N 6-bromo-5-methylpyridine-2-carbonitrile Chemical compound CC1=CC=C(C#N)N=C1Br DHFCAAHDNSOIAE-UHFFFAOYSA-N 0.000 description 1
• FIMGYEKEYXUTGD-UHFFFAOYSA-N 6-methyl-2-oxo-1h-pyridine-3-carbonitrile Chemical compound CC1=CC=C(C#N)C(O)=N1 FIMGYEKEYXUTGD-UHFFFAOYSA-N 0.000 description 1
• FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
• ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
• HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
• QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• 102000012936 Angiostatins Human genes 0.000 description 1
• 108010079709 Angiostatins Proteins 0.000 description 1
• 241000416162 Astragalus gummifer Species 0.000 description 1
• 206010003571 Astrocytoma Diseases 0.000 description 1
• 201000001320 Atherosclerosis Diseases 0.000 description 1
• 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
• 208000023275 Autoimmune disease Diseases 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
• 108010006654 Bleomycin Proteins 0.000 description 1
• 206010055113 Breast cancer metastatic Diseases 0.000 description 1
• FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
• FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
• AMDZAROSCSFBMR-UHFFFAOYSA-N C[Si](C)(C)[S+]1C=NC=C1 Chemical group C[Si](C)(C)[S+]1C=NC=C1 AMDZAROSCSFBMR-UHFFFAOYSA-N 0.000 description 1
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
• 206010011017 Corneal graft rejection Diseases 0.000 description 1
• XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
• 206010012689 Diabetic retinopathy Diseases 0.000 description 1
• LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
• YIIMEMSDCNDGTB-UHFFFAOYSA-N Dimethylcarbamoyl chloride Chemical compound CN(C)C(Cl)=O YIIMEMSDCNDGTB-UHFFFAOYSA-N 0.000 description 1
• 229940124226 Farnesyltransferase inhibitor Drugs 0.000 description 1
• BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
• VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
• 208000010412 Glaucoma Diseases 0.000 description 1
• 206010018338 Glioma Diseases 0.000 description 1
• AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 1
• 239000007995 HEPES buffer Substances 0.000 description 1
• 208000002250 Hematologic Neoplasms Diseases 0.000 description 1
• 208000017604 Hodgkin disease Diseases 0.000 description 1
• 208000021519 Hodgkin lymphoma Diseases 0.000 description 1
• 208000010747 Hodgkins lymphoma Diseases 0.000 description 1
• LELOWRISYMNNSU-UHFFFAOYSA-N Hydrocyanic acid Natural products N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 1
• 206010021143 Hypoxia Diseases 0.000 description 1
• 102000006992 Interferon-alpha Human genes 0.000 description 1
• 108010047761 Interferon-alpha Proteins 0.000 description 1
• 101710163622 Isoprenyl transferase Proteins 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
• JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
• WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
• 239000012448 Lithium borohydride Substances 0.000 description 1
• 206010025323 Lymphomas Diseases 0.000 description 1
• AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
• XOBKSJJDNFUZPF-UHFFFAOYSA-N Methoxyethane Chemical compound CCOC XOBKSJJDNFUZPF-UHFFFAOYSA-N 0.000 description 1
• 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
• MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
• 238000006411 Negishi coupling reaction Methods 0.000 description 1
• 208000003788 Neoplasm Micrometastasis Diseases 0.000 description 1
• 206010029260 Neuroblastoma Diseases 0.000 description 1
• 208000005890 Neuroma Diseases 0.000 description 1
• PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
• MSHZHSPISPJWHW-UHFFFAOYSA-N O-(chloroacetylcarbamoyl)fumagillol Chemical compound O1C(CC=C(C)C)C1(C)C1C(OC)C(OC(=O)NC(=O)CCl)CCC21CO2 MSHZHSPISPJWHW-UHFFFAOYSA-N 0.000 description 1
• CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
• 208000022873 Ocular disease Diseases 0.000 description 1
• 239000005642 Oleic acid Substances 0.000 description 1
• ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
• 108700020796 Oncogene Proteins 0.000 description 1
• 102000043276 Oncogene Human genes 0.000 description 1
• 229930012538 Paclitaxel Natural products 0.000 description 1
• PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
• 208000007452 Plasmacytoma Diseases 0.000 description 1
• 102000004211 Platelet factor 4 Human genes 0.000 description 1
• 108090000778 Platelet factor 4 Proteins 0.000 description 1
• 229920002732 Polyanhydride Polymers 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 229920000954 Polyglycolide Polymers 0.000 description 1
• 229920001710 Polyorthoester Polymers 0.000 description 1
• 201000004681 Psoriasis Diseases 0.000 description 1
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
• 208000007135 Retinal Neovascularization Diseases 0.000 description 1
• 201000000582 Retinoblastoma Diseases 0.000 description 1
• 206010038933 Retinopathy of prematurity Diseases 0.000 description 1
• 206010039491 Sarcoma Diseases 0.000 description 1
• KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
• VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
• UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
• 229910000831 Steel Inorganic materials 0.000 description 1
• 238000006619 Stille reaction Methods 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• 238000006069 Suzuki reaction reaction Methods 0.000 description 1
• 208000031673 T-Cell Cutaneous Lymphoma Diseases 0.000 description 1
• 208000000389 T-cell leukemia Diseases 0.000 description 1
• 208000028530 T-cell lymphoblastic leukemia/lymphoma Diseases 0.000 description 1
• 229920001615 Tragacanth Polymers 0.000 description 1
• OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
• 239000007983 Tris buffer Substances 0.000 description 1
• 229920004890 Triton X-100 Polymers 0.000 description 1
• 239000013504 Triton X-100 Substances 0.000 description 1
• JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 1
• 206010052428 Wound Diseases 0.000 description 1
• 208000027418 Wounds and injury Diseases 0.000 description 1
• IZQQOYGTWXCUTN-UHFFFAOYSA-N [2-(3-chlorophenyl)-1-oxidopyridin-1-ium-3-yl]methanol Chemical compound OCC1=CC=C[N+]([O-])=C1C1=CC=CC(Cl)=C1 IZQQOYGTWXCUTN-UHFFFAOYSA-N 0.000 description 1
• NXYRSYVGNQGQSZ-UHFFFAOYSA-N [2-(3-chlorophenyl)-6-methylpyridin-3-yl]methanol Chemical compound CC1=CC=C(CO)C(C=2C=C(Cl)C=CC=2)=N1 NXYRSYVGNQGQSZ-UHFFFAOYSA-N 0.000 description 1
• PZOZKEANGKKWBO-UHFFFAOYSA-N [2-(3-chlorophenyl)pyridin-3-yl]methanol Chemical compound OCC1=CC=CN=C1C1=CC=CC(Cl)=C1 PZOZKEANGKKWBO-UHFFFAOYSA-N 0.000 description 1
• WOAORAPRPVIATR-UHFFFAOYSA-N [3-(trifluoromethyl)phenyl]boronic acid Chemical group OB(O)C1=CC=CC(C(F)(F)F)=C1 WOAORAPRPVIATR-UHFFFAOYSA-N 0.000 description 1
• ALMFIOZYDASRRC-UHFFFAOYSA-N [4-(trifluoromethyl)phenyl]boronic acid Chemical group OB(O)C1=CC=C(C(F)(F)F)C=C1 ALMFIOZYDASRRC-UHFFFAOYSA-N 0.000 description 1
• SFLCGPKLXMZFCY-UHFFFAOYSA-N [6-chloro-2-(3-chlorophenyl)pyridin-3-yl]methanol Chemical compound OCC1=CC=C(Cl)N=C1C1=CC=CC(Cl)=C1 SFLCGPKLXMZFCY-UHFFFAOYSA-N 0.000 description 1
• 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
• 230000004913 activation Effects 0.000 description 1
• WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
• 210000004100 adrenal gland Anatomy 0.000 description 1
• 229940072056 alginate Drugs 0.000 description 1
• 235000010443 alginic acid Nutrition 0.000 description 1
• 229920000615 alginic acid Polymers 0.000 description 1
• 150000004703 alkoxides Chemical class 0.000 description 1
• 150000003973 alkyl amines Chemical class 0.000 description 1
• 125000002947 alkylene group Chemical group 0.000 description 1
• AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
• XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
• 229910052782 aluminium Inorganic materials 0.000 description 1
• 229940024606 amino acid Drugs 0.000 description 1
• 150000001413 amino acids Chemical class 0.000 description 1
• 229950011175 aminopicoline Drugs 0.000 description 1
• 238000002399 angioplasty Methods 0.000 description 1
• 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
• 239000002246 antineoplastic agent Substances 0.000 description 1
• 239000007900 aqueous suspension Substances 0.000 description 1
• 229910052786 argon Inorganic materials 0.000 description 1
• 229940009098 aspartate Drugs 0.000 description 1
• FZCSTZYAHCUGEM-UHFFFAOYSA-N aspergillomarasmine B Natural products OC(=O)CNC(C(O)=O)CNC(C(O)=O)CC(O)=O FZCSTZYAHCUGEM-UHFFFAOYSA-N 0.000 description 1
• 238000003556 assay Methods 0.000 description 1
• 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 1
• 235000012216 bentonite Nutrition 0.000 description 1
• 229940077388 benzenesulfonate Drugs 0.000 description 1
• SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
• 229940050390 benzoate Drugs 0.000 description 1
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
• 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
• XMIIGOLPHOKFCH-UHFFFAOYSA-N beta-phenylpropanoic acid Natural products OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 1
• 150000005347 biaryls Chemical group 0.000 description 1
• 210000000013 bile duct Anatomy 0.000 description 1
• 229920002988 biodegradable polymer Polymers 0.000 description 1
• 239000004621 biodegradable polymer Substances 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 229960001561 bleomycin Drugs 0.000 description 1
• OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
• 239000008280 blood Substances 0.000 description 1
• 210000004369 blood Anatomy 0.000 description 1
• ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
• 229910052794 bromium Inorganic materials 0.000 description 1
• 239000006172 buffering agent Substances 0.000 description 1
• MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 1
• 230000009702 cancer cell proliferation Effects 0.000 description 1
• 150000001721 carbon Chemical group 0.000 description 1
• 150000005323 carbonate salts Chemical class 0.000 description 1
• 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
• PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
• 239000001913 cellulose Substances 0.000 description 1
• 235000010980 cellulose Nutrition 0.000 description 1
• 229920002678 cellulose Polymers 0.000 description 1
• 230000002490 cerebral effect Effects 0.000 description 1
• 210000003679 cervix uteri Anatomy 0.000 description 1
• KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
• 239000003153 chemical reaction reagent Substances 0.000 description 1
• 238000004296 chiral HPLC Methods 0.000 description 1
• 239000012320 chlorinating reagent Substances 0.000 description 1
• 229910052801 chlorine Inorganic materials 0.000 description 1
• 150000001805 chlorine compounds Chemical class 0.000 description 1
• FCYRSDMGOLYDHL-UHFFFAOYSA-N chloromethoxyethane Chemical compound CCOCCl FCYRSDMGOLYDHL-UHFFFAOYSA-N 0.000 description 1
• 238000004587 chromatography analysis Methods 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 229940001468 citrate Drugs 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• 229940110456 cocoa butter Drugs 0.000 description 1
• 235000019868 cocoa butter Nutrition 0.000 description 1
• 239000003086 colorant Substances 0.000 description 1
• 238000004040 coloring Methods 0.000 description 1
• 238000009833 condensation Methods 0.000 description 1
• 230000005494 condensation Effects 0.000 description 1
• 238000001816 cooling Methods 0.000 description 1
• 239000006071 cream Substances 0.000 description 1
• 201000007241 cutaneous T cell lymphoma Diseases 0.000 description 1
• 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
• 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
• 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
• 229940127089 cytotoxic agent Drugs 0.000 description 1
• 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 238000010511 deprotection reaction Methods 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
• 229960003957 dexamethasone Drugs 0.000 description 1
• LCSNDSFWVKMJCT-UHFFFAOYSA-N dicyclohexyl-(2-phenylphenyl)phosphane Chemical group C1CCCCC1P(C=1C(=CC=CC=1)C=1C=CC=CC=1)C1CCCCC1 LCSNDSFWVKMJCT-UHFFFAOYSA-N 0.000 description 1
• 235000005911 diet Nutrition 0.000 description 1
• 230000037213 diet Effects 0.000 description 1
• 235000014113 dietary fatty acids Nutrition 0.000 description 1
• BGYGAIJKOAKMQH-UHFFFAOYSA-N diethyl 3-(3-chlorophenyl)-4-(hydroxymethylidene)pent-2-enedioate Chemical compound CCOC(=O)C=C(C(=CO)C(=O)OCC)C1=CC=CC(Cl)=C1 BGYGAIJKOAKMQH-UHFFFAOYSA-N 0.000 description 1
• JHCKGVJZNIWNJK-UHFFFAOYSA-N diethyl pent-2-enedioate Chemical compound CCOC(=O)CC=CC(=O)OCC JHCKGVJZNIWNJK-UHFFFAOYSA-N 0.000 description 1
• 125000004655 dihydropyridinyl group Chemical group N1(CC=CC=C1)* 0.000 description 1
• 125000005053 dihydropyrimidinyl group Chemical group N1(CN=CC=C1)* 0.000 description 1
• 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
• GAFRWLVTHPVQGK-UHFFFAOYSA-N dipentyl sulfate Chemical class CCCCCOS(=O)(=O)OCCCCC GAFRWLVTHPVQGK-UHFFFAOYSA-N 0.000 description 1
• 239000001177 diphosphate Substances 0.000 description 1
• XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
• ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
• 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
• 235000019797 dipotassium phosphate Nutrition 0.000 description 1
• 239000002270 dispersing agent Substances 0.000 description 1
• 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 229960004679 doxorubicin Drugs 0.000 description 1
• 239000006196 drop Substances 0.000 description 1
• 239000003995 emulsifying agent Substances 0.000 description 1
• 230000001804 emulsifying effect Effects 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 238000003821 enantio-separation Methods 0.000 description 1
• 210000003372 endocrine gland Anatomy 0.000 description 1
• 239000003623 enhancer Substances 0.000 description 1
• 239000002702 enteric coating Substances 0.000 description 1
• 238000009505 enteric coating Methods 0.000 description 1
• 210000003238 esophagus Anatomy 0.000 description 1
• 238000010931 ester hydrolysis Methods 0.000 description 1
• MGBZXMQPYAYPIQ-UHFFFAOYSA-N ethyl 2-(4-cyanophenyl)-2-oxoacetate Chemical compound CCOC(=O)C(=O)C1=CC=C(C#N)C=C1 MGBZXMQPYAYPIQ-UHFFFAOYSA-N 0.000 description 1
• 230000029142 excretion Effects 0.000 description 1
• 239000003889 eye drop Substances 0.000 description 1
• 229940012356 eye drops Drugs 0.000 description 1
• 208000024519 eye neoplasm Diseases 0.000 description 1
• 239000003885 eye ointment Substances 0.000 description 1
• 239000000194 fatty acid Substances 0.000 description 1
• 229930195729 fatty acid Natural products 0.000 description 1
• 150000004665 fatty acids Chemical class 0.000 description 1
• 210000005002 female reproductive tract Anatomy 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
• 229910052731 fluorine Inorganic materials 0.000 description 1
• NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical class FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
• 239000011888 foil Substances 0.000 description 1
• 239000012634 fragment Substances 0.000 description 1
• MSBPSFSYBUUPMC-UHFFFAOYSA-N furan-2-ylphosphane Chemical compound PC1=CC=CO1 MSBPSFSYBUUPMC-UHFFFAOYSA-N 0.000 description 1
• 125000002541 furyl group Chemical group 0.000 description 1
• 210000000232 gallbladder Anatomy 0.000 description 1
• 239000007789 gas Substances 0.000 description 1
• 208000005017 glioblastoma Diseases 0.000 description 1
• 229930195712 glutamate Natural products 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 201000011066 hemangioma Diseases 0.000 description 1
• 230000009033 hematopoietic malignancy Effects 0.000 description 1
• MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 1
• 125000000592 heterocycloalkyl group Chemical group 0.000 description 1
• FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
• 150000004678 hydrides Chemical class 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
• 230000007062 hydrolysis Effects 0.000 description 1
• 238000006460 hydrolysis reaction Methods 0.000 description 1
• 150000004679 hydroxides Chemical class 0.000 description 1
• RCBVKBFIWMOMHF-UHFFFAOYSA-L hydroxy-(hydroxy(dioxo)chromio)oxy-dioxochromium;pyridine Chemical compound C1=CC=NC=C1.C1=CC=NC=C1.O[Cr](=O)(=O)O[Cr](O)(=O)=O RCBVKBFIWMOMHF-UHFFFAOYSA-L 0.000 description 1
• NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
• 206010020718 hyperplasia Diseases 0.000 description 1
• 210000003026 hypopharynx Anatomy 0.000 description 1
• 230000007954 hypoxia Effects 0.000 description 1
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 1
• 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
• 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
• 239000003701 inert diluent Substances 0.000 description 1
• 238000001802 infusion Methods 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• 229940102223 injectable solution Drugs 0.000 description 1
• 229940102213 injectable suspension Drugs 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 238000011835 investigation Methods 0.000 description 1
• 239000011630 iodine Substances 0.000 description 1
• SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
• 150000002576 ketones Chemical class 0.000 description 1
• 210000003734 kidney Anatomy 0.000 description 1
• 239000008101 lactose Substances 0.000 description 1
• 208000032839 leukemia Diseases 0.000 description 1
• 239000002502 liposome Substances 0.000 description 1
• 239000007788 liquid Substances 0.000 description 1
• 239000008297 liquid dosage form Substances 0.000 description 1
• DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 1
• XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 1
• 229910052808 lithium carbonate Inorganic materials 0.000 description 1
• 229910000103 lithium hydride Inorganic materials 0.000 description 1
• LZWQNOHZMQIFBX-UHFFFAOYSA-N lithium;2-methylpropan-2-olate Chemical compound [Li+].CC(C)(C)[O-] LZWQNOHZMQIFBX-UHFFFAOYSA-N 0.000 description 1
• 239000006210 lotion Substances 0.000 description 1
• 239000000314 lubricant Substances 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• JMZFEHDNIAQMNB-UHFFFAOYSA-N m-aminophenylboronic acid Chemical group NC1=CC=CC(B(O)O)=C1 JMZFEHDNIAQMNB-UHFFFAOYSA-N 0.000 description 1
• 208000002780 macular degeneration Diseases 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
• 235000019341 magnesium sulphate Nutrition 0.000 description 1
• 229940049920 malate Drugs 0.000 description 1
• 210000005001 male reproductive tract Anatomy 0.000 description 1
• VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid group Chemical group C(\C=C/C(=O)O)(=O)O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
• BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
• 239000011159 matrix material Substances 0.000 description 1
• 201000001441 melanoma Diseases 0.000 description 1
• 206010027191 meningioma Diseases 0.000 description 1
• 208000037843 metastatic solid tumor Diseases 0.000 description 1
• QJLSZWUWQIBOMU-UHFFFAOYSA-N methyl 2-(3-chlorophenyl)-4-cyanobenzoate Chemical compound COC(=O)C1=CC=C(C#N)C=C1C1=CC=CC(Cl)=C1 QJLSZWUWQIBOMU-UHFFFAOYSA-N 0.000 description 1
• LRGFJLCSHKYRFS-UHFFFAOYSA-N methyl 2-(3-chlorophenyl)-4-iodobenzoate Chemical compound COC(=O)C1=CC=C(I)C=C1C1=CC=CC(Cl)=C1 LRGFJLCSHKYRFS-UHFFFAOYSA-N 0.000 description 1
• GWFADKSOYHJDGT-UHFFFAOYSA-N methyl 2-(3-chlorophenyl)-4-nitrobenzoate Chemical compound COC(=O)C1=CC=C([N+]([O-])=O)C=C1C1=CC=CC(Cl)=C1 GWFADKSOYHJDGT-UHFFFAOYSA-N 0.000 description 1
• TWNPQXWVXHPIJV-UHFFFAOYSA-N methyl 2-(bromomethyl)-5-cyanobenzoate Chemical compound COC(=O)C1=CC(C#N)=CC=C1CBr TWNPQXWVXHPIJV-UHFFFAOYSA-N 0.000 description 1
• PICNSXCJRMYANX-UHFFFAOYSA-N methyl 2-chloro-4-nitrobenzoate Chemical compound COC(=O)C1=CC=C([N+]([O-])=O)C=C1Cl PICNSXCJRMYANX-UHFFFAOYSA-N 0.000 description 1
• KDNFJYKKFLHZKZ-UHFFFAOYSA-N methyl 3-chloro-4-cyanobenzoate Chemical compound COC(=O)C1=CC=C(C#N)C(Cl)=C1 KDNFJYKKFLHZKZ-UHFFFAOYSA-N 0.000 description 1
• ILDMKNRYCATURZ-UHFFFAOYSA-N methyl 4-amino-2-(3-chlorophenyl)benzoate Chemical compound COC(=O)C1=CC=C(N)C=C1C1=CC=CC(Cl)=C1 ILDMKNRYCATURZ-UHFFFAOYSA-N 0.000 description 1
• AHJLHWRWDRCIKO-UHFFFAOYSA-N methyl 4-cyano-3-fluorobenzoate Chemical compound COC(=O)C1=CC=C(C#N)C(F)=C1 AHJLHWRWDRCIKO-UHFFFAOYSA-N 0.000 description 1
• HMSYIUVOUUPJGH-UHFFFAOYSA-N methyl 5-cyano-2-[[(4-cyanophenyl)-(3-methylimidazol-4-yl)methoxy]methyl]benzoate Chemical compound COC(=O)C1=CC(C#N)=CC=C1COC(C=1C=CC(=CC=1)C#N)C1=CN=CN1C HMSYIUVOUUPJGH-UHFFFAOYSA-N 0.000 description 1
• NLJITVMSLMNYSZ-UHFFFAOYSA-N methyl 5-cyano-2-methylbenzoate Chemical compound COC(=O)C1=CC(C#N)=CC=C1C NLJITVMSLMNYSZ-UHFFFAOYSA-N 0.000 description 1
• ANXKZXRDXAZQJT-UHFFFAOYSA-M methyl sulfate;trimethylsulfanium Chemical compound C[S+](C)C.COS([O-])(=O)=O ANXKZXRDXAZQJT-UHFFFAOYSA-M 0.000 description 1
• 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
• DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 description 1
• 239000003094 microcapsule Substances 0.000 description 1
• 239000008108 microcrystalline cellulose Substances 0.000 description 1
• 229940016286 microcrystalline cellulose Drugs 0.000 description 1
• 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
• 239000002480 mineral oil Substances 0.000 description 1
• 235000010446 mineral oil Nutrition 0.000 description 1
• 150000007522 mineralic acids Chemical class 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
• 235000019796 monopotassium phosphate Nutrition 0.000 description 1
• 201000005962 mycosis fungoides Diseases 0.000 description 1
• 201000005987 myeloid sarcoma Diseases 0.000 description 1
• 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• OIFLDARYLFULQA-UHFFFAOYSA-N n-[2-[[(4-cyanophenyl)-(3-methylimidazol-4-yl)methoxy]methyl]-5-iodophenyl]thiophene-2-sulfonamide Chemical compound CN1C=NC=C1C(C=1C=CC(=CC=1)C#N)OCC1=CC=C(I)C=C1NS(=O)(=O)C1=CC=CS1 OIFLDARYLFULQA-UHFFFAOYSA-N 0.000 description 1
• DPKDWERTWMZACY-UHFFFAOYSA-N n-[5-cyano-2-[[(4-cyanophenyl)-(3-methylimidazol-4-yl)methoxy]methyl]phenyl]-4-methylbenzenesulfonamide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC1=CC(C#N)=CC=C1COC(C=1C=CC(=CC=1)C#N)C1=CN=CN1C DPKDWERTWMZACY-UHFFFAOYSA-N 0.000 description 1
• KVBGVZZKJNLNJU-UHFFFAOYSA-M naphthalene-2-sulfonate Chemical compound C1=CC=CC2=CC(S(=O)(=O)[O-])=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-M 0.000 description 1
• 125000001624 naphthyl group Chemical group 0.000 description 1
• 239000007922 nasal spray Substances 0.000 description 1
• 201000003142 neovascular glaucoma Diseases 0.000 description 1
• 210000005036 nerve Anatomy 0.000 description 1
• 239000011570 nicotinamide Substances 0.000 description 1
• 229960003966 nicotinamide Drugs 0.000 description 1
• 239000011664 nicotinic acid Substances 0.000 description 1
• 235000001968 nicotinic acid Nutrition 0.000 description 1
• 125000004433 nitrogen atom Chemical group N* 0.000 description 1
• 231100000344 non-irritating Toxicity 0.000 description 1
• 239000000346 nonvolatile oil Substances 0.000 description 1
• 230000000414 obstructive effect Effects 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
• 231100000590 oncogenic Toxicity 0.000 description 1
• 230000002246 oncogenic effect Effects 0.000 description 1
• 150000007524 organic acids Chemical class 0.000 description 1
• 235000005985 organic acids Nutrition 0.000 description 1
• 210000003300 oropharynx Anatomy 0.000 description 1
• 230000003204 osmotic effect Effects 0.000 description 1
• 201000008482 osteoarthritis Diseases 0.000 description 1
• 210000001672 ovary Anatomy 0.000 description 1
• 230000001590 oxidative effect Effects 0.000 description 1
• 125000003232 p-nitrobenzoyl group Chemical group [N+](=O)([O-])C1=CC=C(C(=O)*)C=C1 0.000 description 1
• 108010054353 p21(ras) farnesyl-protein transferase Proteins 0.000 description 1
• 229960001592 paclitaxel Drugs 0.000 description 1
• PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 1
• UQPUONNXJVWHRM-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 UQPUONNXJVWHRM-UHFFFAOYSA-N 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• 239000006072 paste Substances 0.000 description 1
• 229940043138 pentosan polysulfate Drugs 0.000 description 1
• 239000002304 perfume Substances 0.000 description 1
• JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 1
• ANRQGKOBLBYXFM-UHFFFAOYSA-M phenylmagnesium bromide Chemical compound Br[Mg]C1=CC=CC=C1 ANRQGKOBLBYXFM-UHFFFAOYSA-M 0.000 description 1
• UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
• 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 1
• 235000011007 phosphoric acid Nutrition 0.000 description 1
• 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
• PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
• 150000003016 phosphoric acids Chemical class 0.000 description 1
• 125000001557 phthalyl group Chemical group C(=O)(O)C1=C(C(=O)*)C=CC=C1 0.000 description 1
• 229940075930 picrate Drugs 0.000 description 1
• OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 description 1
• 230000001817 pituitary effect Effects 0.000 description 1
• 229920001296 polysiloxane Polymers 0.000 description 1
• 239000011736 potassium bicarbonate Substances 0.000 description 1
• 235000015497 potassium bicarbonate Nutrition 0.000 description 1
• 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
• IUBQJLUDMLPAGT-UHFFFAOYSA-N potassium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([K])[Si](C)(C)C IUBQJLUDMLPAGT-UHFFFAOYSA-N 0.000 description 1
• 235000003270 potassium fluoride Nutrition 0.000 description 1
• NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
• 229910000105 potassium hydride Inorganic materials 0.000 description 1
• TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
• 229910000160 potassium phosphate Inorganic materials 0.000 description 1
• 235000011009 potassium phosphates Nutrition 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 208000025638 primary cutaneous T-cell non-Hodgkin lymphoma Diseases 0.000 description 1
• CPTBDICYNRMXFX-UHFFFAOYSA-N procarbazine Chemical compound CNNCC1=CC=C(C(=O)NC(C)C)C=C1 CPTBDICYNRMXFX-UHFFFAOYSA-N 0.000 description 1
• 229960000624 procarbazine Drugs 0.000 description 1
• 230000002035 prolonged effect Effects 0.000 description 1
• 229940056457 promace Drugs 0.000 description 1
• 239000003380 propellant Substances 0.000 description 1
• 238000011321 prophylaxis Methods 0.000 description 1
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 210000002307 prostate Anatomy 0.000 description 1
• 239000012264 purified product Substances 0.000 description 1
• 125000003373 pyrazinyl group Chemical group 0.000 description 1
• PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
• 125000004076 pyridyl group Chemical group 0.000 description 1
• 125000000714 pyrimidinyl group Chemical group 0.000 description 1
• KXJJSKYICDAICD-UHFFFAOYSA-N quinolin-8-ylboronic acid Chemical group C1=CN=C2C(B(O)O)=CC=CC2=C1 KXJJSKYICDAICD-UHFFFAOYSA-N 0.000 description 1
• 230000005855 radiation Effects 0.000 description 1
• 108700042226 ras Genes Proteins 0.000 description 1
• 238000001953 recrystallisation Methods 0.000 description 1
• 208000037803 restenosis Diseases 0.000 description 1
• 230000000284 resting effect Effects 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 238000002821 scintillation proximity assay Methods 0.000 description 1
• 210000001625 seminal vesicle Anatomy 0.000 description 1
• 208000017520 skin disease Diseases 0.000 description 1
• 210000000813 small intestine Anatomy 0.000 description 1
• 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
• AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• 239000001632 sodium acetate Substances 0.000 description 1
• 235000017281 sodium acetate Nutrition 0.000 description 1
• 235000017557 sodium bicarbonate Nutrition 0.000 description 1
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
• WRIKHQLVHPKCJU-UHFFFAOYSA-N sodium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([Na])[Si](C)(C)C WRIKHQLVHPKCJU-UHFFFAOYSA-N 0.000 description 1
• WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical class [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 1
• 239000012279 sodium borohydride Substances 0.000 description 1
• 229910000033 sodium borohydride Inorganic materials 0.000 description 1
• 239000011780 sodium chloride Substances 0.000 description 1
• BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
• 239000012312 sodium hydride Substances 0.000 description 1
• 235000010288 sodium nitrite Nutrition 0.000 description 1
• 239000012321 sodium triacetoxyborohydride Substances 0.000 description 1
• 239000007909 solid dosage form Substances 0.000 description 1
• 238000004611 spectroscopical analysis Methods 0.000 description 1
• 239000010959 steel Substances 0.000 description 1
• 239000011550 stock solution Substances 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• 235000011044 succinic acid Nutrition 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid group Chemical group C(CCC(=O)O)(=O)O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• 125000004434 sulfur atom Chemical group 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 238000001356 surgical procedure Methods 0.000 description 1
• 239000003765 sweetening agent Substances 0.000 description 1
• 238000010189 synthetic method Methods 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
• 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 210000001550 testis Anatomy 0.000 description 1
• YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
• 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 1
• 229960003433 thalidomide Drugs 0.000 description 1
• 125000001544 thienyl group Chemical group 0.000 description 1
• 210000001685 thyroid gland Anatomy 0.000 description 1
• 210000001519 tissue Anatomy 0.000 description 1
• JOXIMZWYDAKGHI-UHFFFAOYSA-M toluene-4-sulfonate Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-M 0.000 description 1
• 239000006208 topical dosage form Substances 0.000 description 1
• 239000000196 tragacanth Substances 0.000 description 1
• 235000010487 tragacanth Nutrition 0.000 description 1
• 229940116362 tragacanth Drugs 0.000 description 1
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
• NSYSSMYQPLSPOD-UHFFFAOYSA-N triacetate lactone Chemical compound CC1=CC(O)=CC(=O)O1 NSYSSMYQPLSPOD-UHFFFAOYSA-N 0.000 description 1
• TUQOTMZNTHZOKS-UHFFFAOYSA-N tributylphosphine Chemical compound CCCCP(CCCC)CCCC TUQOTMZNTHZOKS-UHFFFAOYSA-N 0.000 description 1
• LEIMLDGFXIOXMT-UHFFFAOYSA-N trimethylsilyl cyanide Chemical compound C[Si](C)(C)C#N LEIMLDGFXIOXMT-UHFFFAOYSA-N 0.000 description 1
• 230000005740 tumor formation Effects 0.000 description 1
• 238000000825 ultraviolet detection Methods 0.000 description 1
• JABYJIQOLGWMQW-UHFFFAOYSA-N undec-4-ene Chemical compound CCCCCCC=CCCC JABYJIQOLGWMQW-UHFFFAOYSA-N 0.000 description 1
• ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 1
• 210000003932 urinary bladder Anatomy 0.000 description 1
• 230000002485 urinary effect Effects 0.000 description 1
• 210000001635 urinary tract Anatomy 0.000 description 1
• 210000003741 urothelium Anatomy 0.000 description 1
• 210000004291 uterus Anatomy 0.000 description 1
• 210000001215 vagina Anatomy 0.000 description 1
• 230000002792 vascular Effects 0.000 description 1
• 235000019871 vegetable fat Nutrition 0.000 description 1
• 201000010653 vesiculitis Diseases 0.000 description 1
• 229960003048 vinblastine Drugs 0.000 description 1
• JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 description 1
• 239000001993 wax Substances 0.000 description 1
• 150000003738 xylenes Chemical class 0.000 description 1
• 229910052725 zinc Inorganic materials 0.000 description 1
• 239000011787 zinc oxide Substances 0.000 description 1
• 235000014692 zinc oxide Nutrition 0.000 description 1